| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.678 | 0.003 | 0.678 | Alcohol oxidase inhibitor | 0.414 0.004 CHEMBL33232 0.067 0.031 CHEMBL1647 | ||
| 0.677 | 0.003 | 0.823 | Alpha-N-acetylglucosaminidase inhibitor | 0.269 0.02 CHEMBL3544802 0.413 0.008 CHEMBL33232 0.823 0.002 CHEMBL1647 0.497 0.005 CHEMBL3544871 | CHEMBL1647 | |
| 0.678 | 0.026 | 0.678 | Caspase 9 stimulant | 0.459 0.078 CHEMBL33232 0.635 0.032 CHEMBL1647 | ||
| 0.646 | 0.004 | 0.723 | Peroxidase inhibitor | 0.323 0.033 CHEMBL3544802 0.431 0.016 CHEMBL33232 0.723 0.003 CHEMBL3544870 0.42 0.018 CHEMBL3544871 | CHEMBL3544870 | |
| 0.61 | 0.01 | 0.673 | 5 Hydroxytryptamine release inhibitor | 0.261 0.212 CHEMBL3544802 0.48 0.039 CHEMBL33232 0.673 0.005 CHEMBL1647 | CHEMBL1647 | |
| 0.575 | 0.013 | 0.698 | Histamine release inhibitor | 0.497 0.03 CHEMBL3544802 0.428 0.061 CHEMBL33232 0.698 0.005 CHEMBL1647 0.501 0.028 CHEMBL3544870 0.445 0.052 CHEMBL3544871 | CHEMBL1647 | |
| 0.569 | 0.011 | 0.569 | GABA C receptor rho-3 antagonist | 0.546 0.015 CHEMBL33232 | ||
| 0.559 | 0.025 | 0.559 | Aldehyde oxidase inhibitor | 0.545 0.027 CHEMBL33232 | ||
| 0.498 | 0.029 | 0.498 | Calcium channel L-type activator | 0.324 0.137 CHEMBL33232 0.231 0.228 CHEMBL1647 | ||
| 0.469 | 0.012 | 0.528 | Interleukin 2 agonist | 0.314 0.064 CHEMBL3544802 0.277 0.092 CHEMBL33232 0.528 0.005 CHEMBL1647 0.416 0.023 CHEMBL3544870 0.414 0.024 CHEMBL3544871 | CHEMBL1647 | |
| 0.462 | 0.012 | 0.616 | Interleukin agonist | 0.177 0.142 CHEMBL3544802 0.307 0.044 CHEMBL33232 0.616 0.004 CHEMBL1647 0.347 0.03 CHEMBL3544870 0.333 0.034 CHEMBL3544871 | CHEMBL1647 | |
| 0.476 | 0.045 | 0.476 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.303 0.208 CHEMBL3544802 0.468 0.05 CHEMBL33232 | ||
| 0.445 | 0.03 | 0.445 | Aryl hydrocarbon receptor agonist | 0.199 0.102 CHEMBL33232 | ||
| 0.41 | 0.007 | 0.41 | Tyrosine 3 hydroxylase inhibitor | 0.185 0.165 CHEMBL3544802 0.319 0.025 CHEMBL33232 0.199 0.137 CHEMBL3544870 0.239 0.079 CHEMBL3544871 | ||
| 0.482 | 0.086 | 0.727 | Alpha-glucosidase inhibitor | 0.226 0.202 CHEMBL3544802 0.263 0.18 CHEMBL33232 0.727 0.029 CHEMBL1647 | CHEMBL1647 | |
| 0.427 | 0.032 | 0.427 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.34 0.053 CHEMBL33232 0.275 0.071 CHEMBL3544871 | ||
| 0.405 | 0.026 | 0.463 | Superoxide dismutase inhibitor | 0.463 0.017 CHEMBL3544802 0.322 0.043 CHEMBL33232 0.244 0.078 CHEMBL3544870 0.209 0.108 CHEMBL3544871 | CHEMBL3544802 | |
| 0.401 | 0.031 | 0.536 | Interleukin antagonist | 0.181 0.095 CHEMBL1647 0.536 0.017 CHEMBL3544870 0.391 0.032 CHEMBL3544871 | CHEMBL3544870 | |
| 0.387 | 0.022 | 0.403 | Transcription factor STAT inhibitor | 0.275 0.071 CHEMBL33232 0.18 0.167 CHEMBL1647 0.316 0.047 CHEMBL3544870 0.403 0.018 CHEMBL3544871 | CHEMBL3544871 | |
| 0.381 | 0.019 | 0.381 | Anesthetic general | 0.223 0.063 CHEMBL33232 0.356 0.023 CHEMBL1647 | ||
| 0.361 | 0.011 | 0.361 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.294 0.026 CHEMBL33232 0.293 0.026 CHEMBL1647 0.164 0.119 CHEMBL3544871 | ||
| 0.372 | 0.026 | 0.427 | Transcription factor STAT3 inhibitor | 0.242 0.09 CHEMBL33232 0.214 0.117 CHEMBL1647 0.36 0.029 CHEMBL3544870 0.427 0.014 CHEMBL3544871 | CHEMBL3544871 | |
| 0.401 | 0.061 | 0.401 | Calpain 2 inhibitor | 0.245 0.153 CHEMBL33232 0.276 0.131 CHEMBL3544870 0.32 0.102 CHEMBL3544871 | ||
| 0.341 | 0.005 | 0.341 | Ferrochelatase inhibitor | 0.126 0.05 CHEMBL3544802 0.302 0.007 CHEMBL33232 | ||
| 0.341 | 0.005 | 0.341 | Carbonic anhydrase III inhibitor | 0.281 0.006 CHEMBL3544802 0.168 0.023 CHEMBL33232 0.203 0.015 CHEMBL1647 0.118 0.046 CHEMBL3544871 | ||
| 0.392 | 0.058 | 0.392 | Vasodilator, peripheral | 0.205 0.171 CHEMBL33232 0.372 0.065 CHEMBL1647 | ||
| 0.34 | 0.008 | 0.478 | UDP-glucose 4-epimerase inhibitor | 0.099 0.062 CHEMBL3544802 0.252 0.013 CHEMBL33232 0.478 0.003 CHEMBL1647 | CHEMBL1647 | |
| 0.376 | 0.046 | 0.376 | 12-Lipoxygenase inhibitor | 0.235 0.118 CHEMBL33232 | ||
| 0.403 | 0.073 | 0.403 | 15-Lipoxygenase inhibitor | 0.255 0.16 CHEMBL3544802 0.345 0.102 CHEMBL33232 | ||
| 0.355 | 0.032 | 0.378 | Insulysin inhibitor | 0.193 0.167 CHEMBL3544802 0.303 0.057 CHEMBL33232 0.378 0.026 CHEMBL3544870 0.3 0.058 CHEMBL3544871 | CHEMBL3544870 | |
| 0.322 | 0.009 | 0.474 | Hexokinase inhibitor | 0.13 0.105 CHEMBL3544802 0.196 0.038 CHEMBL33232 0.474 0.003 CHEMBL1647 0.25 0.017 CHEMBL3544871 | CHEMBL1647 | |
| 0.421 | 0.111 | 0.421 | DNA polymerase beta inhibitor | |||
| 0.317 | 0.007 | 0.317 | Carbonic anhydrase XV inhibitor | 0.169 0.025 CHEMBL3544802 0.18 0.022 CHEMBL33232 | ||
| 0.314 | 0.005 | 0.7 | Cyclooxygenase 3 inhibitor | 0.122 0.076 CHEMBL3544802 0.173 0.032 CHEMBL33232 0.7 0.002 CHEMBL1647 0.179 0.028 CHEMBL3544870 0.239 0.01 CHEMBL3544871 | CHEMBL1647 | |
| 0.41 | 0.111 | 0.41 | DNA directed DNA polymerase inhibitor | |||
| 0.316 | 0.019 | 0.446 | Peptidyltransferase inhibitor | 0.181 0.127 CHEMBL3544802 0.234 0.063 CHEMBL33232 0.446 0.005 CHEMBL1647 0.312 0.02 CHEMBL3544870 0.318 0.019 CHEMBL3544871 | CHEMBL1647 | |
| 0.317 | 0.02 | 0.317 | 5 Hydroxytryptamine 1E antagonist | 0.173 0.162 CHEMBL3544802 0.221 0.107 CHEMBL33232 | ||
| 0.325 | 0.034 | 0.325 | 5 Hydroxytryptamine uptake stimulant | 0.305 0.042 CHEMBL33232 | ||
| 0.3 | 0.011 | 0.3 | Nitric-oxide synthase stimulant | 0.25 0.032 CHEMBL33232 0.295 0.013 CHEMBL1647 | ||
| 0.294 | 0.007 | 0.294 | Death-associated protein kinase 2 inhibitor | 0.162 0.082 CHEMBL3544802 0.151 0.103 CHEMBL33232 | ||
| 0.287 | 0.009 | 0.287 | Interleukin 4 antagonist | 0.118 0.089 CHEMBL33232 0.206 0.021 CHEMBL1647 | ||
| 0.29 | 0.012 | 0.29 | Succinate dehydrogenase inhibitor | 0.201 0.048 CHEMBL3544802 0.269 0.017 CHEMBL33232 0.156 0.101 CHEMBL1647 0.169 0.081 CHEMBL3544871 | ||
| 0.344 | 0.067 | 0.626 | Cholesterol antagonist | 0.432 0.043 CHEMBL3544802 0.248 0.126 CHEMBL33232 0.626 0.015 CHEMBL1647 | CHEMBL1647 | |
| 0.297 | 0.02 | 0.297 | Neuropeptide Y2 antagonist | 0.201 0.117 CHEMBL33232 0.228 0.079 CHEMBL3544870 0.218 0.09 CHEMBL3544871 | ||
| 0.352 | 0.076 | 0.677 | Transcription factor NF kappa B inhibitor | 0.245 0.131 CHEMBL33232 0.677 0.023 CHEMBL1647 0.413 0.061 CHEMBL3544870 0.423 0.059 CHEMBL3544871 | CHEMBL1647 | |
| 0.329 | 0.055 | 0.451 | Sodium/bile acid cotransporter inhibitor | 0.244 0.135 CHEMBL3544802 0.248 0.13 CHEMBL1647 0.451 0.007 CHEMBL3544870 0.382 0.023 CHEMBL3544871 | CHEMBL3544870 | |
| 0.292 | 0.02 | 0.298 | Neurotrophic factor enhancer | 0.238 0.046 CHEMBL33232 0.298 0.018 CHEMBL1647 | CHEMBL1647 | |
| 0.337 | 0.068 | 0.589 | Immunostimulant | 0.384 0.054 CHEMBL3544802 0.215 0.112 CHEMBL33232 0.589 0.018 CHEMBL1647 0.557 0.022 CHEMBL3544870 0.387 0.053 CHEMBL3544871 | CHEMBL1647 | |
| 0.327 | 0.062 | 0.327 | 5 Hydroxytryptamine release stimulant | 0.268 0.081 CHEMBL33232 0.194 0.127 CHEMBL1647 | ||
| 0.264 | 0.009 | 0.356 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.084 0.075 CHEMBL3544802 0.185 0.018 CHEMBL33232 0.356 0.004 CHEMBL1647 0.149 0.027 CHEMBL3544870 0.168 0.022 CHEMBL3544871 | CHEMBL1647 | |
| 0.269 | 0.02 | 0.269 | 3C-like protease (Human coronavirus) inhibitor | 0.231 0.036 CHEMBL33232 | ||
| 0.254 | 0.007 | 0.254 | Porphobilinogen synthase inhibitor | 0.097 0.037 CHEMBL3544802 0.246 0.008 CHEMBL33232 | ||
| 0.248 | 0.005 | 0.248 | Papain-like protease (SARS coronavirus) inhibitor | 0.141 0.044 CHEMBL3544802 0.145 0.039 CHEMBL33232 0.125 0.069 CHEMBL1647 0.127 0.066 CHEMBL3544871 | ||
| 0.246 | 0.006 | 0.246 | Creatine kinase inhibitor | 0.1 0.06 CHEMBL3544802 0.185 0.013 CHEMBL33232 | ||
| 0.282 | 0.047 | 0.282 | Gastrin inhibitor | 0.189 0.166 CHEMBL3544802 0.234 0.1 CHEMBL33232 0.245 0.085 CHEMBL1647 0.26 0.068 CHEMBL3544870 0.244 0.086 CHEMBL3544871 | ||
| 0.285 | 0.051 | 0.285 | Pyruvate kinase inhibitor | 0.231 0.067 CHEMBL33232 | ||
| 0.257 | 0.024 | 0.544 | Phospholipase C inhibitor | 0.261 0.023 CHEMBL3544802 0.156 0.094 CHEMBL33232 0.205 0.041 CHEMBL1647 0.544 0.005 CHEMBL3544870 0.22 0.033 CHEMBL3544871 | CHEMBL3544870 | |
| 0.253 | 0.02 | 0.253 | NADPH oxidase inhibitor | 0.115 0.089 CHEMBL33232 0.178 0.041 CHEMBL1647 | ||
| 0.271 | 0.038 | 0.362 | DNA methyltransferase I inhibitor | 0.362 0.012 CHEMBL1647 0.269 0.039 CHEMBL3544870 0.319 0.02 CHEMBL3544871 | CHEMBL1647 | |
| 0.286 | 0.055 | 0.561 | Free radical scavenger | 0.561 0.011 CHEMBL1647 0.269 0.061 CHEMBL3544870 0.28 0.057 CHEMBL3544871 | CHEMBL1647 | |
| 0.232 | 0.004 | 0.248 | Neuraminidase (influenza) inhibitor | 0.248 0.004 CHEMBL3544802 0.224 0.004 CHEMBL1647 0.074 0.03 CHEMBL3544870 0.114 0.013 CHEMBL3544871 | CHEMBL3544802 | |
| 0.236 | 0.012 | 0.26 | Toll-Like receptor 2 antagonist | 0.18 0.034 CHEMBL33232 0.104 0.098 CHEMBL1647 0.26 0.008 CHEMBL3544870 0.224 0.015 CHEMBL3544871 | CHEMBL3544870 | |
| 0.307 | 0.085 | 0.307 | Calcium channel activator | 0.288 0.104 CHEMBL33232 | ||
| 0.351 | 0.13 | 0.351 | Transcription factor inhibitor | 0.264 0.177 CHEMBL33232 | ||
| 0.231 | 0.01 | 0.231 | CF transmembrane conductance regulator agonist | 0.163 0.055 CHEMBL33232 0.173 0.043 CHEMBL1647 | ||
| 0.241 | 0.02 | 0.241 | 5 Hydroxytryptamine 3E antagonist | 0.194 0.073 CHEMBL3544802 0.235 0.024 CHEMBL33232 | ||
| 0.224 | 0.004 | 0.224 | Neuraminidase inhibitor | 0.218 0.004 CHEMBL3544802 0.2 0.004 CHEMBL1647 0.076 0.029 CHEMBL3544870 0.116 0.01 CHEMBL3544871 | ||
| 0.306 | 0.09 | 0.422 | Thyroid hormone antagonist | 0.2 0.162 CHEMBL3544870 0.422 0.049 CHEMBL3544871 | CHEMBL3544871 | |
| 0.234 | 0.018 | 0.383 | ATPase inhibitor | 0.138 0.125 CHEMBL33232 0.383 0.004 CHEMBL1647 | CHEMBL1647 | |
| 0.226 | 0.011 | 0.274 | Catalase inhibitor | 0.274 0.007 CHEMBL3544802 0.088 0.043 CHEMBL33232 0.229 0.011 CHEMBL3544870 0.206 0.014 CHEMBL3544871 | CHEMBL3544802 | |
| 0.263 | 0.048 | 0.263 | MAP kinase kinase 2 inhibitor | |||
| 0.229 | 0.016 | 0.229 | GABA C receptor agonist | 0.184 0.024 CHEMBL33232 | ||
| 0.241 | 0.03 | 0.241 | Heat shock protein 90 alpha antagonist | 0.145 0.092 CHEMBL33232 | ||
| 0.22 | 0.011 | 0.41 | Histidine decarboxylase inhibitor | 0.099 0.032 CHEMBL33232 0.41 0.004 CHEMBL3544870 0.096 0.033 CHEMBL3544871 | CHEMBL3544870 | |
| 0.252 | 0.048 | 0.33 | RNA-directed DNA polymerase inhibitor | 0.33 0.027 CHEMBL3544802 0.218 0.076 CHEMBL33232 0.214 0.081 CHEMBL1647 | CHEMBL3544802 | |
| 0.227 | 0.025 | 0.227 | M17 leucyl aminopeptidase inhibitor | 0.191 0.036 CHEMBL3544871 | ||
| 0.222 | 0.02 | 0.222 | Cystathionine beta-synthase inhibitor | 0.151 0.04 CHEMBL33232 0.173 0.032 CHEMBL1647 | ||
| 0.229 | 0.027 | 0.483 | Monophenol monooxygenase inhibitor | 0.097 0.078 CHEMBL3544802 0.101 0.075 CHEMBL33232 0.483 0.008 CHEMBL1647 | CHEMBL1647 | |
| 0.273 | 0.073 | 0.617 | Antioxidant | 0.317 0.056 CHEMBL3544802 0.617 0.01 CHEMBL1647 0.269 0.074 CHEMBL3544870 0.272 0.073 CHEMBL3544871 | CHEMBL1647 | |
| 0.208 | 0.009 | 0.208 | Sphingosine 1-phosphate receptor 5 antagonist | 0.147 0.067 CHEMBL33232 | ||
| 0.21 | 0.011 | 0.306 | Mucolytic | 0.11 0.065 CHEMBL3544802 0.126 0.049 CHEMBL33232 0.219 0.01 CHEMBL1647 0.235 0.008 CHEMBL3544870 0.306 0.004 CHEMBL3544871 | CHEMBL3544871 | |
| 0.218 | 0.02 | 0.218 | GABA C receptor rho-2 antagonist | 0.21 0.024 CHEMBL33232 | ||
| 0.29 | 0.093 | 0.386 | Thyroid hormone beta antagonist | 0.386 0.058 CHEMBL3544871 | CHEMBL3544871 | |
| 0.209 | 0.012 | 0.209 | Carbonic anhydrase VI inhibitor | 0.168 0.017 CHEMBL3544802 0.104 0.037 CHEMBL33232 0.088 0.048 CHEMBL1647 | ||
| 0.223 | 0.026 | 0.223 | Neurotensin receptor agonist | 0.16 0.08 CHEMBL33232 0.213 0.029 CHEMBL3544870 0.194 0.038 CHEMBL3544871 | ||
| 0.318 | 0.122 | 0.654 | Antibacterial | 0.44 0.06 CHEMBL3544802 0.453 0.056 CHEMBL33232 0.654 0.013 CHEMBL1647 0.316 0.123 CHEMBL3544870 0.384 0.084 CHEMBL3544871 | CHEMBL1647 | |
| 0.21 | 0.015 | 0.21 | Falcipain 3 inhibitor | 0.153 0.035 CHEMBL33232 0.114 0.058 CHEMBL3544871 | ||
| 0.252 | 0.057 | 0.252 | Amyloid beta aggregation inhibitor | 0.153 0.106 CHEMBL1647 | ||
| 0.242 | 0.053 | 0.361 | DNA methylase inhibitor | 0.361 0.015 CHEMBL1647 0.269 0.039 CHEMBL3544870 0.297 0.029 CHEMBL3544871 | CHEMBL1647 | |
| 0.252 | 0.063 | 0.252 | Calpain inhibitor | 0.19 0.123 CHEMBL33232 0.238 0.076 CHEMBL3544870 0.226 0.088 CHEMBL3544871 | ||
| 0.224 | 0.036 | 0.508 | Amylase inhibitor | 0.508 0.005 CHEMBL1647 | CHEMBL1647 | |
| 0.283 | 0.098 | 0.503 | Apoptosis antagonist | 0.503 0.02 CHEMBL1647 0.32 0.073 CHEMBL3544870 0.311 0.078 CHEMBL3544871 | CHEMBL1647 | |
| 0.251 | 0.066 | 0.406 | DNA synthesis inhibitor | 0.241 0.073 CHEMBL33232 0.406 0.021 CHEMBL1647 0.185 0.147 CHEMBL3544871 | CHEMBL1647 | |
| 0.219 | 0.035 | 0.389 | Protein kinase stimulant | 0.11 0.105 CHEMBL33232 0.389 0.009 CHEMBL1647 | CHEMBL1647 | |
| 0.187 | 0.008 | 0.187 | Phenylalanine 4-hydroxylase inhibitor | 0.109 0.022 CHEMBL33232 0.076 0.04 CHEMBL3544870 0.122 0.018 CHEMBL3544871 | ||
| 0.194 | 0.015 | 0.434 | Carbonic anhydrase XIII inhibitor | 0.434 0.004 CHEMBL3544802 0.091 0.042 CHEMBL33232 0.197 0.014 CHEMBL1647 | CHEMBL3544802 | |
| 0.189 | 0.011 | 0.189 | Sphingosine 1-phosphate receptor 2 antagonist | 0.121 0.094 CHEMBL3544802 0.126 0.083 CHEMBL33232 | ||
| 0.236 | 0.059 | 0.236 | ErbB-1 antagonist | |||
| 0.197 | 0.021 | 0.523 | Expectorant | 0.095 0.074 CHEMBL33232 0.523 0.003 CHEMBL1647 0.23 0.015 CHEMBL3544870 0.298 0.009 CHEMBL3544871 | CHEMBL1647 | |
| 0.206 | 0.03 | 0.206 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.243 | 0.067 | 0.389 | Cyclic AMP phosphodiesterase inhibitor | 0.26 0.059 CHEMBL33232 0.389 0.018 CHEMBL1647 | CHEMBL1647 | |
| 0.203 | 0.03 | 0.203 | Catenin beta inhibitor | 0.147 0.112 CHEMBL3544870 0.159 0.085 CHEMBL3544871 | ||
| 0.181 | 0.009 | 0.477 | Carbonic anhydrase V inhibitor | 0.477 0.003 CHEMBL3544802 0.099 0.027 CHEMBL33232 0.063 0.05 CHEMBL3544871 | CHEMBL3544802 | |
| 0.2 | 0.03 | 0.394 | Cell wall synthesis inhibitor | 0.347 0.008 CHEMBL3544802 0.164 0.052 CHEMBL33232 0.394 0.006 CHEMBL1647 0.158 0.058 CHEMBL3544870 0.178 0.042 CHEMBL3544871 | CHEMBL1647 | |
| 0.207 | 0.039 | 0.332 | Lipid peroxidase inhibitor | 0.118 0.096 CHEMBL3544802 0.332 0.015 CHEMBL1647 0.135 0.079 CHEMBL3544870 0.125 0.088 CHEMBL3544871 | CHEMBL1647 | |
| 0.215 | 0.048 | 0.215 | Amyloid beta precursor protein antagonist | |||
| 0.172 | 0.006 | 0.223 | NMDA receptor agonist | 0.223 0.004 CHEMBL3544802 0.079 0.029 CHEMBL33232 0.137 0.01 CHEMBL3544870 0.147 0.008 CHEMBL3544871 | CHEMBL3544802 | |
| 0.202 | 0.037 | 0.202 | Heat shock protein 90 antagonist | 0.121 0.112 CHEMBL33232 | ||
| 0.169 | 0.004 | 0.169 | D-Ala-D-Ala ligase inhibitor | 0.101 0.028 CHEMBL33232 | ||
| 0.177 | 0.013 | 0.183 | Heat shock protein 70 antagonist | 0.144 0.062 CHEMBL33232 0.183 0.01 CHEMBL1647 0.133 0.105 CHEMBL3544871 | CHEMBL1647 | |
| 0.203 | 0.039 | 0.349 | NOS3 expression enhancer | 0.236 0.03 CHEMBL33232 0.349 0.012 CHEMBL1647 | CHEMBL1647 | |
| 0.256 | 0.096 | 0.256 | Lipoxygenase inhibitor | 0.229 0.115 CHEMBL33232 | ||
| 0.27 | 0.111 | 0.689 | Antithrombotic | 0.465 0.035 CHEMBL3544802 0.689 0.009 CHEMBL1647 0.296 0.09 CHEMBL3544870 0.197 0.181 CHEMBL3544871 | CHEMBL1647 | |
| 0.173 | 0.014 | 0.173 | CDK3/cyclin E inhibitor | 0.097 0.093 CHEMBL3544802 0.107 0.075 CHEMBL3544871 | ||
| 0.204 | 0.046 | 0.204 | Cytidine deaminase inhibitor | 0.152 0.073 CHEMBL33232 | ||
| 0.172 | 0.015 | 0.5 | Triose-phosphate isomerase inhibitor | 0.5 0.002 CHEMBL3544802 0.241 0.007 CHEMBL33232 0.349 0.004 CHEMBL1647 | CHEMBL3544802 | |
| 0.215 | 0.059 | 0.262 | Insulin sensitizer | 0.148 0.136 CHEMBL3544802 0.212 0.062 CHEMBL33232 0.209 0.064 CHEMBL1647 0.262 0.028 CHEMBL3544870 0.242 0.039 CHEMBL3544871 | CHEMBL3544870 | |
| 0.164 | 0.008 | 0.323 | Carbonic anhydrase VA inhibitor | 0.323 0.003 CHEMBL3544802 0.101 0.025 CHEMBL33232 0.073 0.043 CHEMBL3544871 | CHEMBL3544802 | |
| 0.187 | 0.036 | 0.235 | Histone deacetylase SIRT1 inhibitor | 0.118 0.093 CHEMBL33232 0.235 0.021 CHEMBL3544870 0.195 0.032 CHEMBL3544871 | CHEMBL3544870 | |
| 0.188 | 0.037 | 0.188 | M18 aspartyl aminopeptidase inhibitor | 0.1 0.092 CHEMBL33232 | ||
| 0.194 | 0.043 | 0.355 | Interferon gamma antagonist | 0.186 0.047 CHEMBL33232 0.355 0.014 CHEMBL1647 | CHEMBL1647 | |
| 0.165 | 0.014 | 0.165 | Transcription factor STAT6 inhibitor | 0.139 0.033 CHEMBL33232 | ||
| 0.257 | 0.106 | 0.312 | Caspase 3 stimulant | 0.312 0.073 CHEMBL1647 0.199 0.171 CHEMBL3544870 0.246 0.115 CHEMBL3544871 | CHEMBL1647 | |
| 0.157 | 0.006 | 0.157 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.053 0.048 CHEMBL33232 0.152 0.007 CHEMBL1647 | ||
| 0.154 | 0.004 | 0.154 | NMDA receptor glycine site agonist | 0.091 0.022 CHEMBL3544802 0.098 0.017 CHEMBL33232 0.056 0.05 CHEMBL3544870 0.108 0.013 CHEMBL3544871 | ||
| 0.191 | 0.041 | 0.21 | Arachidonic acid antagonist | 0.21 0.024 CHEMBL33232 | CHEMBL33232 | |
| 0.177 | 0.028 | 0.177 | Adenylate cyclase stimulant | 0.156 0.054 CHEMBL3544802 0.156 0.054 CHEMBL33232 0.122 0.121 CHEMBL1647 | ||
| 0.179 | 0.029 | 0.179 | Protein kinase (CK2) alpha inhibitor | |||
| 0.164 | 0.015 | 0.164 | DOPA decarboxylase inhibitor | 0.142 0.026 CHEMBL33232 | ||
| 0.169 | 0.019 | 0.169 | HIV-1 integrase (Overall Integration) inhibitor | 0.093 0.061 CHEMBL3544802 0.105 0.05 CHEMBL33232 | ||
| 0.251 | 0.102 | 0.251 | Streptokinase A inhibitor | |||
| 0.168 | 0.02 | 0.168 | Sphingosine 1-phosphate receptor 4 antagonist | 0.142 0.041 CHEMBL33232 | ||
| 0.16 | 0.013 | 0.16 | Keratolytic | 0.089 0.038 CHEMBL33232 | ||
| 0.168 | 0.022 | 0.168 | GABA C receptor antagonist | 0.111 0.063 CHEMBL3544802 0.137 0.038 CHEMBL33232 | ||
| 0.19 | 0.045 | 0.342 | Melanin inhibitor | 0.139 0.098 CHEMBL33232 0.342 0.017 CHEMBL1647 | CHEMBL1647 | |
| 0.164 | 0.019 | 0.164 | Androgen antagonist | 0.092 0.053 CHEMBL33232 | ||
| 0.205 | 0.061 | 0.205 | LIM domain kinase 1 inhibitor | |||
| 0.202 | 0.061 | 0.202 | Growth factor agonist | |||
| 0.159 | 0.019 | 0.159 | Urease inhibitor | 0.108 0.058 CHEMBL33232 | ||
| 0.141 | 0.003 | 0.141 | Dihydroorotate oxidase inhibitor | 0.081 0.01 CHEMBL3544802 0.076 0.013 CHEMBL33232 | ||
| 0.256 | 0.119 | 0.593 | Angiogenesis inhibitor | 0.593 0.017 CHEMBL3544802 0.39 0.057 CHEMBL1647 | CHEMBL3544802 | |
| 0.165 | 0.028 | 0.165 | 5 Hydroxytryptamine 3A agonist | 0.16 0.03 CHEMBL33232 | ||
| 0.179 | 0.043 | 0.213 | Alkaline phosphatase inhibitor | 0.213 0.029 CHEMBL3544802 0.182 0.041 CHEMBL1647 | CHEMBL3544802 | |
| 0.157 | 0.021 | 0.157 | Estrogen antagonist | |||
| 0.22 | 0.084 | 0.765 | Angiogenesis stimulant | 0.499 0.012 CHEMBL3544802 0.765 0.004 CHEMBL1647 0.384 0.024 CHEMBL3544870 0.336 0.037 CHEMBL3544871 | CHEMBL1647 | |
| 0.152 | 0.017 | 0.294 | NADH dehydrogenase inhibitor | 0.093 0.053 CHEMBL3544802 0.183 0.012 CHEMBL33232 0.294 0.007 CHEMBL1647 | CHEMBL1647 | |
| 0.149 | 0.016 | 0.149 | Estrogen receptor beta antagonist | |||
| 0.156 | 0.024 | 0.18 | Caspase 3 inhibitor | 0.128 0.048 CHEMBL33232 0.155 0.025 CHEMBL3544870 0.18 0.014 CHEMBL3544871 | CHEMBL3544871 | |
| 0.153 | 0.02 | 0.153 | GABA C receptor rho-1 antagonist | 0.139 0.027 CHEMBL33232 | ||
| 0.15 | 0.018 | 0.157 | Anabolic | 0.157 0.014 CHEMBL3544802 0.141 0.023 CHEMBL33232 0.097 0.067 CHEMBL3544870 | CHEMBL3544802 | |
| 0.201 | 0.07 | 0.201 | I kappa B kinase epsilon inhibitor | 0.139 0.132 CHEMBL33232 | ||
| 0.152 | 0.021 | 0.152 | Prolactin inhibitor | 0.081 0.08 CHEMBL33232 | ||
| 0.17 | 0.039 | 0.17 | Neuropeptide Y1 antagonist | |||
| 0.258 | 0.129 | 0.386 | Thioredoxin glutathione reductase inhibitor | 0.386 0.062 CHEMBL33232 0.245 0.138 CHEMBL3544871 | CHEMBL33232 | |
| 0.138 | 0.01 | 0.244 | Carbonic anhydrase VB inhibitor | 0.244 0.004 CHEMBL3544802 0.072 0.027 CHEMBL33232 | CHEMBL3544802 | |
| 0.173 | 0.047 | 0.502 | Hemostatic | 0.481 0.005 CHEMBL3544802 0.502 0.004 CHEMBL1647 0.156 0.061 CHEMBL3544870 | CHEMBL1647 | |
| 0.154 | 0.028 | 0.154 | TRPA1 agonist | 0.126 0.051 CHEMBL3544802 0.115 0.064 CHEMBL33232 | ||
| 0.132 | 0.006 | 0.132 | Topoisomerase II beta inhibitor | 0.053 0.029 CHEMBL33232 0.089 0.011 CHEMBL1647 | ||
| 0.133 | 0.008 | 0.133 | Beta 3 adrenoreceptor antagonist | |||
| 0.161 | 0.036 | 0.161 | Pregnane X receptor agonist | 0.132 0.094 CHEMBL3544802 0.137 0.081 CHEMBL33232 | ||
| 0.223 | 0.098 | 0.248 | DNA damaging | 0.202 0.113 CHEMBL33232 0.248 0.081 CHEMBL1647 | CHEMBL1647 | |
| 0.129 | 0.005 | 0.129 | GABA B receptor agonist | 0.082 0.037 CHEMBL33232 | ||
| 0.155 | 0.031 | 0.155 | Ca2+-transporting ATPase inhibitor | 0.154 0.033 CHEMBL33232 0.15 0.041 CHEMBL1647 | ||
| 0.134 | 0.011 | 0.134 | GABA aminotransferase inhibitor | 0.085 0.041 CHEMBL33232 0.116 0.018 CHEMBL1647 | ||
| 0.157 | 0.035 | 0.322 | Aminopeptidase B inhibitor | 0.188 0.024 CHEMBL3544802 0.113 0.056 CHEMBL33232 0.322 0.007 CHEMBL3544870 0.159 0.034 CHEMBL3544871 | CHEMBL3544870 | |
| 0.145 | 0.022 | 0.145 | Alcohol dehydrogenase inhibitor | 0.103 0.049 CHEMBL33232 0.113 0.04 CHEMBL1647 0.111 0.042 CHEMBL3544870 | ||
| 0.138 | 0.015 | 0.281 | Glutamate decarboxylase inhibitor | 0.127 0.018 CHEMBL33232 0.281 0.004 CHEMBL3544870 0.097 0.031 CHEMBL3544871 | CHEMBL3544870 | |
| 0.151 | 0.028 | 0.399 | Mediator release inhibitor | 0.088 0.084 CHEMBL33232 0.399 0.005 CHEMBL1647 | CHEMBL1647 | |
| 0.155 | 0.033 | 0.155 | Vanilloid 1 agonist | 0.125 0.077 CHEMBL3544802 0.12 0.088 CHEMBL33232 0.142 0.048 CHEMBL1647 0.145 0.044 CHEMBL3544870 | ||
| 0.138 | 0.017 | 0.146 | Interleukin 12 antagonist | 0.146 0.014 CHEMBL1647 | CHEMBL1647 | |
| 0.125 | 0.004 | 0.125 | Dihydropteroate synthase inhibitor | 0.052 0.015 CHEMBL3544802 0.04 0.026 CHEMBL33232 | ||
| 0.127 | 0.006 | 0.127 | CC chemokine 5 receptor agonist | 0.111 0.013 CHEMBL3544802 0.082 0.058 CHEMBL33232 | ||
| 0.158 | 0.038 | 0.171 | Histone deacetylase class III inhibitor | 0.171 0.03 CHEMBL3544870 0.147 0.046 CHEMBL3544871 | CHEMBL3544870 | |
| 0.128 | 0.007 | 0.128 | Estrogen-related receptor beta agonist | 0.095 0.031 CHEMBL33232 | ||
| 0.141 | 0.021 | 0.141 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.088 0.045 CHEMBL33232 | ||
| 0.125 | 0.005 | 0.125 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.146 | 0.028 | 0.153 | Adenylate kinase inhibitor | 0.102 0.065 CHEMBL3544802 0.153 0.025 CHEMBL33232 0.117 0.046 CHEMBL1647 0.112 0.051 CHEMBL3544870 0.094 0.078 CHEMBL3544871 | CHEMBL33232 | |
| 0.141 | 0.023 | 0.141 | Potassium channel activator | 0.081 0.074 CHEMBL33232 | ||
| 0.151 | 0.033 | 0.151 | Interleukin 8 antagonist | 0.114 0.07 CHEMBL33232 | ||
| 0.159 | 0.043 | 0.159 | Farnesoid X receptor antagonist | 0.121 0.101 CHEMBL3544871 | ||
| 0.135 | 0.019 | 0.135 | Adrenaline agonist | |||
| 0.14 | 0.024 | 0.14 | Electrolyte absorption antagonist | 0.114 0.042 CHEMBL33232 | ||
| 0.292 | 0.178 | 0.572 | Apoptosis agonist | 0.572 0.055 CHEMBL1647 0.395 0.116 CHEMBL3544870 0.439 0.096 CHEMBL3544871 | CHEMBL1647 | |
| 0.128 | 0.014 | 0.181 | Glycine receptor antagonist | 0.181 0.004 CHEMBL3544802 0.093 0.039 CHEMBL33232 0.18 0.004 CHEMBL1647 | CHEMBL3544802 | |
| 0.122 | 0.008 | 0.122 | Carbonic anhydrase VII inhibitor | 0.055 0.023 CHEMBL3544802 0.072 0.015 CHEMBL33232 0.052 0.025 CHEMBL1647 | ||
| 0.208 | 0.094 | 0.298 | Antiamyloidogenic | 0.298 0.052 CHEMBL1647 | CHEMBL1647 | |
| 0.18 | 0.068 | 0.322 | Growth hormone agonist | 0.322 0.028 CHEMBL3544870 0.204 0.057 CHEMBL3544871 | CHEMBL3544870 | |
| 0.202 | 0.091 | 0.202 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.155 | 0.044 | 0.301 | Alkylator | 0.113 0.075 CHEMBL3544802 0.096 0.093 CHEMBL33232 0.301 0.013 CHEMBL1647 0.118 0.07 CHEMBL3544870 | CHEMBL1647 | |
| 0.151 | 0.041 | 0.151 | MAO A inhibitor | 0.082 0.079 CHEMBL33232 | ||
| 0.115 | 0.005 | 0.115 | MAP kinase kinase 7 inhibitor | 0.082 0.039 CHEMBL33232 | ||
| 0.145 | 0.035 | 0.145 | Protein kinase (CK2) inhibitor | |||
| 0.136 | 0.026 | 0.214 | Topoisomerase II alpha inhibitor | 0.214 0.013 CHEMBL1647 0.088 0.047 CHEMBL3544870 0.091 0.045 CHEMBL3544871 | CHEMBL1647 | |
| 0.247 | 0.138 | 0.416 | Vasodilator, coronary | 0.195 0.187 CHEMBL33232 0.416 0.03 CHEMBL1647 | CHEMBL1647 | |
| 0.155 | 0.046 | 0.155 | Anesthetic local | |||
| 0.126 | 0.019 | 0.58 | Glutathione S-transferase inhibitor | 0.107 0.031 CHEMBL33232 0.074 0.073 CHEMBL1647 0.58 0.001 CHEMBL3544870 0.282 0.003 CHEMBL3544871 | CHEMBL3544870 | |
| 0.152 | 0.045 | 0.152 | Cathepsin H inhibitor | 0.152 0.045 CHEMBL33232 | ||
| 0.148 | 0.042 | 0.148 | Death-associated protein kinase 1 inhibitor | |||
| 0.15 | 0.045 | 0.15 | Adenylate cyclase inhibitor | 0.094 0.09 CHEMBL33232 | ||
| 0.128 | 0.023 | 0.128 | Glutamate (mGluR7) agonist | 0.107 0.047 CHEMBL33232 | ||
| 0.117 | 0.012 | 0.117 | Purinergic P2X1 antagonist | 0.056 0.05 CHEMBL3544802 0.082 0.024 CHEMBL33232 0.058 0.046 CHEMBL1647 | ||
| 0.125 | 0.021 | 0.155 | Glutamate dehydrogenase inhibitor | 0.072 0.054 CHEMBL3544802 0.114 0.025 CHEMBL33232 0.084 0.041 CHEMBL1647 0.155 0.015 CHEMBL3544870 0.136 0.019 CHEMBL3544871 | CHEMBL3544870 | |
| 0.189 | 0.085 | 0.189 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.133 | 0.03 | 0.133 | NMDA receptor antagonist | 0.109 0.041 CHEMBL3544802 | ||
| 0.129 | 0.028 | 0.163 | Interleukin 1 beta converting enzyme inhibitor | 0.163 0.013 CHEMBL33232 0.123 0.033 CHEMBL3544871 | CHEMBL33232 | |
| 0.124 | 0.023 | 0.159 | NMDA 2 receptor antagonist | 0.159 0.015 CHEMBL3544802 | CHEMBL3544802 | |
| 0.149 | 0.048 | 0.149 | Aldehyde dehydrogenase inhibitor | 0.126 0.065 CHEMBL33232 0.12 0.071 CHEMBL1647 | ||
| 0.134 | 0.034 | 0.354 | Beta glucuronidase inhibitor | 0.111 0.055 CHEMBL33232 0.354 0.005 CHEMBL1647 | CHEMBL1647 | |
| 0.184 | 0.084 | 0.407 | Non-steroidal antiinflammatory agent | 0.407 0.013 CHEMBL1647 0.139 0.131 CHEMBL3544871 | CHEMBL1647 | |
| 0.139 | 0.04 | 0.213 | Chelator | 0.213 0.022 CHEMBL3544870 0.115 0.059 CHEMBL3544871 | CHEMBL3544870 | |
| 0.112 | 0.012 | 0.112 | NMDA 2C receptor antagonist | 0.091 0.019 CHEMBL3544802 0.056 0.052 CHEMBL3544870 | ||
| 0.103 | 0.004 | 0.105 | Neuraminidase (Influenza A) inhibitor | 0.059 0.013 CHEMBL3544802 0.045 0.033 CHEMBL33232 0.105 0.004 CHEMBL1647 0.052 0.022 CHEMBL3544870 0.066 0.009 CHEMBL3544871 | CHEMBL1647 | |
| 0.138 | 0.039 | 0.202 | Photosensitizer | 0.161 0.025 CHEMBL33232 0.202 0.012 CHEMBL1647 | CHEMBL1647 | |
| 0.14 | 0.042 | 0.269 | DNA repair enzyme inhibitor | 0.144 0.037 CHEMBL33232 0.269 0.005 CHEMBL1647 | CHEMBL1647 | |
| 0.126 | 0.029 | 0.126 | MAP kinase kinase 1 inhibitor | 0.105 0.05 CHEMBL33232 | ||
| 0.106 | 0.009 | 0.163 | Carbonic anhydrase XIV inhibitor | 0.055 0.028 CHEMBL3544802 0.055 0.028 CHEMBL33232 0.163 0.005 CHEMBL1647 | CHEMBL1647 | |
| 0.131 | 0.034 | 0.183 | Toll-Like receptor 4 antagonist | 0.183 0.009 CHEMBL1647 0.09 0.088 CHEMBL3544870 | CHEMBL1647 | |
| 0.154 | 0.061 | 0.213 | Mannose-6-phosphate isomerase inhibitor | 0.213 0.024 CHEMBL33232 0.164 0.053 CHEMBL1647 | CHEMBL33232 | |
| 0.107 | 0.017 | 0.107 | Biliverdin reductase inhibitor | 0.107 0.017 CHEMBL33232 0.069 0.033 CHEMBL1647 | ||
| 0.193 | 0.102 | 0.193 | Dyrk kinase inhibitor | |||
| 0.127 | 0.037 | 0.127 | Potassium channel (Ca-activated) activator | |||
| 0.143 | 0.053 | 0.159 | Antibacterial (Helicobacter pylori) | 0.137 0.059 CHEMBL3544802 0.11 0.099 CHEMBL3544870 0.159 0.039 CHEMBL3544871 | CHEMBL3544871 | |
| 0.111 | 0.022 | 0.111 | Granulocyte macrophage colony stimulating factor agonist | 0.111 0.022 CHEMBL33232 | ||
| 0.159 | 0.071 | 0.159 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.218 | 0.131 | 0.245 | Hypoxia-inducible factor 1 alpha inhibitor | 0.183 0.174 CHEMBL33232 0.245 0.105 CHEMBL1647 | CHEMBL1647 | |
| 0.119 | 0.032 | 0.119 | Lanosterol 14 alpha demethylase inhibitor | 0.102 0.053 CHEMBL33232 | ||
| 0.102 | 0.015 | 0.102 | Beta adrenoreceptor antagonist | |||
| 0.097 | 0.012 | 0.097 | Heat shock protein 90 beta antagonist | |||
| 0.094 | 0.01 | 0.094 | Cyclin D1 inhibitor | 0.067 0.032 CHEMBL33232 | ||
| 0.146 | 0.062 | 0.146 | MAO inhibitor | 0.104 0.087 CHEMBL33232 | ||
| 0.094 | 0.012 | 0.094 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.049 0.044 CHEMBL3544802 0.059 0.031 CHEMBL33232 | ||
| 0.111 | 0.029 | 0.111 | Bile acid receptor antagonist | 0.106 0.037 CHEMBL3544802 0.086 0.085 CHEMBL33232 | ||
| 0.097 | 0.016 | 0.097 | Androgen agonist | 0.075 0.027 CHEMBL3544802 0.079 0.024 CHEMBL33232 | ||
| 0.091 | 0.013 | 0.091 | Histone deacetylase SIRT3 inhibitor | 0.063 0.04 CHEMBL33232 0.065 0.037 CHEMBL3544870 | ||
| 0.123 | 0.046 | 0.198 | Xanthine oxidase inhibitor | 0.198 0.02 CHEMBL1647 | CHEMBL1647 | |
| 0.217 | 0.139 | 0.217 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.132 | 0.057 | 0.158 | Proteasome inhibitor | 0.158 0.042 CHEMBL3544870 0.148 0.048 CHEMBL3544871 | CHEMBL3544870 | |
| 0.135 | 0.061 | 0.135 | MAP kinase kinase inhibitor | |||
| 0.093 | 0.019 | 0.093 | Potassium channel (ATP-sensitive) blocker | |||
| 0.101 | 0.027 | 0.136 | Aminopeptidase I inhibitor | 0.083 0.039 CHEMBL33232 0.136 0.015 CHEMBL3544870 0.085 0.038 CHEMBL3544871 | CHEMBL3544870 | |
| 0.127 | 0.054 | 0.127 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.099 | 0.027 | 0.099 | Adenosine A3 receptor antagonist | |||
| 0.131 | 0.059 | 0.272 | Topoisomerase II inhibitor | 0.272 0.021 CHEMBL1647 | CHEMBL1647 | |
| 0.148 | 0.076 | 0.293 | Phospholipase A2 inhibitor | 0.128 0.104 CHEMBL1647 0.293 0.014 CHEMBL3544870 0.198 0.043 CHEMBL3544871 | CHEMBL3544870 | |
| 0.078 | 0.007 | 0.078 | Purinergic P2X4 antagonist | |||
| 0.084 | 0.013 | 0.084 | NMDA receptor subunit 3B antagonist | |||
| 0.084 | 0.013 | 0.112 | Sphingosine kinase inhibitor | 0.112 0.005 CHEMBL3544802 | CHEMBL3544802 | |
| 0.102 | 0.031 | 0.197 | Phosphofructokinase-1 inhibitor | 0.094 0.034 CHEMBL33232 0.197 0.011 CHEMBL1647 | CHEMBL1647 | |
| 0.082 | 0.011 | 0.082 | Beta 2 adrenoreceptor antagonist | |||
| 0.176 | 0.105 | 0.176 | Histone acetyltransferase inhibitor | |||
| 0.217 | 0.146 | 0.259 | Prostaglandin dehydrogenase inhibitor | 0.259 0.122 CHEMBL33232 | CHEMBL33232 | |
| 0.085 | 0.015 | 0.085 | Beta 1 adrenoreceptor antagonist | |||
| 0.08 | 0.009 | 0.08 | Beta 2 adrenoreceptor agonist | |||
| 0.097 | 0.028 | 0.273 | Carbonic anhydrase inhibitor | 0.273 0.005 CHEMBL3544802 0.074 0.038 CHEMBL33232 0.093 0.03 CHEMBL1647 | CHEMBL3544802 | |
| 0.104 | 0.035 | 0.104 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.076 | 0.007 | 0.076 | Nicotinic acid receptor agonist | |||
| 0.078 | 0.009 | 0.078 | CDK5/p25 inhibitor | |||
| 0.108 | 0.039 | 0.155 | Phosphodiesterase 6D inhibitor | 0.155 0.008 CHEMBL1647 | CHEMBL1647 | |
| 0.103 | 0.034 | 0.103 | Vanilloid antagonist | |||
| 0.076 | 0.008 | 0.363 | Heparanase inhibitor | 0.13 0.003 CHEMBL3544802 0.052 0.04 CHEMBL33232 0.363 0.001 CHEMBL1647 | CHEMBL1647 | |
| 0.087 | 0.02 | 0.093 | Acyl-CoA dehydrogenase inhibitor | 0.093 0.018 CHEMBL33232 | CHEMBL33232 | |
| 0.119 | 0.053 | 0.119 | Protein kinase C gamma inhibitor | |||
| 0.099 | 0.034 | 0.099 | Telomerase inhibitor | |||
| 0.072 | 0.008 | 0.072 | Dopamine D5 agonist | |||
| 0.081 | 0.018 | 0.081 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.073 | 0.01 | 0.073 | Dihydroorotase inhibitor | |||
| 0.081 | 0.019 | 0.081 | NMDA 2A receptor antagonist | 0.074 0.022 CHEMBL3544870 | ||
| 0.135 | 0.074 | 0.135 | Aurora-C kinase inhibitor | |||
| 0.074 | 0.014 | 0.074 | CD45 antagonist | 0.062 0.019 CHEMBL3544870 0.053 0.029 CHEMBL3544871 | ||
| 0.09 | 0.03 | 0.09 | Amidase inhibitor | |||
| 0.069 | 0.01 | 0.069 | AICAR transformylase inhibitor | 0.059 0.015 CHEMBL3544802 0.056 0.017 CHEMBL3544870 0.06 0.014 CHEMBL3544871 | ||
| 0.104 | 0.046 | 0.127 | Protein kinase C zeta inhibitor | 0.127 0.028 CHEMBL3544802 | CHEMBL3544802 | |
| 0.112 | 0.055 | 0.112 | CDC-like kinase 3 inhibitor | |||
| 0.077 | 0.019 | 0.077 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.081 | 0.024 | 0.081 | Maillard reaction inhibitor | |||
| 0.071 | 0.014 | 0.071 | Carbonic anhydrase IV inhibitor | 0.05 0.025 CHEMBL3544802 0.045 0.028 CHEMBL33232 0.048 0.026 CHEMBL3544870 0.056 0.021 CHEMBL3544871 | ||
| 0.082 | 0.024 | 0.138 | Carbonic anhydrase II inhibitor | 0.138 0.012 CHEMBL3544802 0.066 0.031 CHEMBL33232 0.067 0.031 CHEMBL1647 | CHEMBL3544802 | |
| 0.084 | 0.027 | 0.084 | Carbamoyl phosphate synthetase inhibitor | 0.078 0.029 CHEMBL33232 | ||
| 0.081 | 0.025 | 0.159 | Carbonic anhydrase I inhibitor | 0.159 0.009 CHEMBL3544802 0.066 0.031 CHEMBL33232 0.071 0.029 CHEMBL1647 | CHEMBL3544802 | |
| 0.086 | 0.03 | 0.086 | Secretase beta inhibitor | 0.071 0.047 CHEMBL3544871 | ||
| 0.081 | 0.026 | 0.086 | Glutamate (mGluR7) antagonist | 0.086 0.021 CHEMBL33232 | CHEMBL33232 | |
| 0.074 | 0.018 | 0.146 | Factor IXa inhibitor | 0.146 0.004 CHEMBL3544802 0.127 0.005 CHEMBL1647 | CHEMBL3544802 | |
| 0.147 | 0.092 | 0.375 | Mcl-1 antagonist | 0.193 0.059 CHEMBL3544870 0.375 0.013 CHEMBL3544871 | CHEMBL3544871 | |
| 0.118 | 0.063 | 0.162 | Microtubule formation inhibitor | 0.104 0.084 CHEMBL33232 0.162 0.032 CHEMBL1647 | CHEMBL1647 | |
| 0.149 | 0.095 | 0.441 | Dual specificity phosphatase inhibitor | 0.441 0.01 CHEMBL3544802 0.146 0.098 CHEMBL3544871 | CHEMBL3544802 | |
| 0.061 | 0.007 | 0.061 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.043 0.026 CHEMBL33232 | ||
| 0.086 | 0.032 | 0.086 | Glycine receptor agonist | 0.066 0.064 CHEMBL33232 0.075 0.046 CHEMBL1647 | ||
| 0.068 | 0.014 | 0.068 | CXC chemokine 1 receptor antagonist | |||
| 0.057 | 0.004 | 0.058 | Thyroid hormone agonist | 0.058 0.004 CHEMBL3544802 | CHEMBL3544802 | |
| 0.111 | 0.058 | 0.34 | AMP-activated protein kinase stimulant | 0.34 0.004 CHEMBL1647 | CHEMBL1647 | |
| 0.067 | 0.014 | 0.067 | Immunoglobulin Fc receptor antagonist | 0.056 0.034 CHEMBL33232 | ||
| 0.084 | 0.032 | 0.299 | HIV-1 integrase (3'-Processing) inhibitor | 0.299 0.005 CHEMBL3544802 0.055 0.054 CHEMBL1647 | CHEMBL3544802 | |
| 0.159 | 0.108 | 0.165 | Psychostimulant | 0.165 0.104 CHEMBL1647 | CHEMBL1647 | |
| 0.074 | 0.024 | 0.074 | Transcription factor RelA inhibitor | 0.071 0.028 CHEMBL33232 | ||
| 0.086 | 0.035 | 0.086 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.073 | 0.022 | 0.073 | Botulinum neurotoxin type A inhibitor | 0.054 0.047 CHEMBL33232 0.057 0.042 CHEMBL3544870 | ||
| 0.095 | 0.045 | 0.095 | Bcr-Abl kinase inhibitor | |||
| 0.099 | 0.049 | 0.138 | Thioredoxin inhibitor | 0.133 0.023 CHEMBL33232 0.138 0.021 CHEMBL1647 | CHEMBL1647 | |
| 0.06 | 0.01 | 0.06 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.066 | 0.017 | 0.069 | Lysophosphatidic acid 3 receptor antagonist | 0.051 0.034 CHEMBL33232 0.063 0.019 CHEMBL3544870 0.069 0.015 CHEMBL3544871 | CHEMBL3544871 | |
| 0.056 | 0.008 | 0.056 | Glutamate (mGluR8) agonist | 0.043 0.019 CHEMBL33232 0.039 0.025 CHEMBL3544870 0.046 0.015 CHEMBL3544871 | ||
| 0.064 | 0.016 | 0.064 | Potassium channel (Inward rectifier) activator | 0.059 0.021 CHEMBL3544802 0.061 0.019 CHEMBL33232 | ||
| 0.066 | 0.019 | 0.103 | Adenine nucleotide translocase inhibitor | 0.103 0.004 CHEMBL3544802 0.08 0.009 CHEMBL1647 0.082 0.008 CHEMBL3544870 0.055 0.04 CHEMBL3544871 | CHEMBL3544802 | |
| 0.067 | 0.02 | 0.09 | DNA helicase inhibitor | 0.058 0.031 CHEMBL3544870 0.09 0.008 CHEMBL3544871 | CHEMBL3544871 | |
| 0.056 | 0.01 | 0.056 | Beta adrenoreceptor agonist | |||
| 0.074 | 0.028 | 0.137 | Carbonic anhydrase XII inhibitor | 0.137 0.014 CHEMBL3544802 0.051 0.038 CHEMBL33232 0.135 0.014 CHEMBL1647 | CHEMBL3544802 | |
| 0.092 | 0.046 | 0.092 | Myeloperoxidase inhibitor | |||
| 0.065 | 0.02 | 0.065 | Leukotriene C antagonist | 0.053 0.05 CHEMBL33232 | ||
| 0.061 | 0.015 | 0.061 | Potassium channel (ATP-sensitive) activator | 0.056 0.02 CHEMBL3544802 0.058 0.018 CHEMBL33232 | ||
| 0.065 | 0.021 | 0.171 | Alpha-mannosidase inhibitor | 0.077 0.012 CHEMBL3544802 0.171 0.004 CHEMBL1647 | CHEMBL1647 | |
| 0.062 | 0.017 | 0.091 | Glucose-6-phosphate isomerase inhibitor | 0.057 0.021 CHEMBL33232 0.091 0.006 CHEMBL1647 | CHEMBL1647 | |
| 0.072 | 0.029 | 0.081 | Argininosuccinate synthase inhibitor | 0.081 0.025 CHEMBL33232 | CHEMBL33232 | |
| 0.084 | 0.042 | 0.084 | Histone deacetylase SIRT2 inhibitor | 0.066 0.061 CHEMBL3544870 | ||
| 0.048 | 0.006 | 0.048 | NMDA receptor glycine site antagonist | |||
| 0.101 | 0.059 | 0.106 | Sphingomyelinase inhibitor | 0.106 0.053 CHEMBL33232 0.092 0.07 CHEMBL1647 | CHEMBL33232 | |
| 0.142 | 0.101 | 0.242 | Interleukin 6 antagonist | 0.242 0.025 CHEMBL1647 0.142 0.101 CHEMBL3544870 0.185 0.05 CHEMBL3544871 | CHEMBL1647 | |
| 0.072 | 0.031 | 0.111 | Carbonic anhydrase IX inhibitor | 0.111 0.018 CHEMBL3544802 0.069 0.033 CHEMBL33232 0.09 0.023 CHEMBL1647 | CHEMBL3544802 | |
| 0.07 | 0.029 | 0.134 | Ribonucleoside-diphosphate reductase inhibitor | 0.134 0.014 CHEMBL3544870 0.067 0.03 CHEMBL3544871 | CHEMBL3544870 | |
| 0.05 | 0.009 | 0.05 | Cyclin E2 inhibitor | |||
| 0.065 | 0.025 | 0.065 | Ryanodine receptor antagonist | 0.058 0.043 CHEMBL33232 | ||
| 0.071 | 0.031 | 0.128 | Ribonucleotide reductase inhibitor | 0.128 0.015 CHEMBL3544870 0.067 0.033 CHEMBL3544871 | CHEMBL3544870 | |
| 0.085 | 0.045 | 0.148 | Macrophage migration inhibitory factor inhibitor | 0.148 0.016 CHEMBL33232 | CHEMBL33232 | |
| 0.094 | 0.054 | 0.102 | Glutamate release inhibitor | 0.1 0.043 CHEMBL33232 0.102 0.04 CHEMBL1647 | CHEMBL1647 | |
| 0.097 | 0.057 | 0.097 | Potassium channel (Voltage-sensitive) activator | |||
| 0.092 | 0.053 | 0.092 | Histamine N-methyltransferase inhibitor | |||
| 0.053 | 0.014 | 0.053 | Sphingosine kinase 1 inhibitor | |||
| 0.057 | 0.018 | 0.057 | NMDA receptor subunit 3A antagonist | |||
| 0.063 | 0.024 | 0.197 | Glycine transporter 2 inhibitor | 0.197 0.005 CHEMBL3544870 | CHEMBL3544870 | |
| 0.042 | 0.003 | 0.042 | Nicotinic acid receptor 1 antagonist | 0.016 0.014 CHEMBL33232 | ||
| 0.043 | 0.004 | 0.043 | Estrogen-related receptor gamma antagonist | |||
| 0.041 | 0.003 | 0.041 | Neuraminidase (Influenza B) inhibitor | 0.021 0.015 CHEMBL33232 0.027 0.006 CHEMBL1647 | ||
| 0.073 | 0.035 | 0.073 | Glutamate (mGluR6) antagonist | 0.068 0.043 CHEMBL33232 | ||
| 0.066 | 0.029 | 0.078 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.069 0.026 CHEMBL33232 0.078 0.021 CHEMBL1647 | CHEMBL1647 | |
| 0.051 | 0.014 | 0.051 | Diamine oxidase inhibitor | |||
| 0.052 | 0.015 | 0.052 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.069 | 0.033 | 0.069 | I kappa B kinase 2 inhibitor | |||
| 0.13 | 0.094 | 0.494 | Diuretic | 0.494 0.008 CHEMBL3544802 0.213 0.04 CHEMBL33232 0.29 0.024 CHEMBL1647 | CHEMBL3544802 | |
| 0.065 | 0.03 | 0.065 | Fatty acid synthase inhibitor | |||
| 0.14 | 0.105 | 0.431 | Dual specificity phosphatase 3 inhibitor | 0.431 0.011 CHEMBL3544802 | CHEMBL3544802 | |
| 0.071 | 0.036 | 0.076 | Protease 3C (Human rhinovirus) inhibitor | 0.076 0.03 CHEMBL3544802 0.069 0.038 CHEMBL33232 0.064 0.045 CHEMBL3544870 | CHEMBL3544802 | |
| 0.156 | 0.122 | 0.156 | Focal adhesion kinase 2 inhibitor | 0.147 0.136 CHEMBL33232 | ||
| 0.132 | 0.098 | 0.372 | Protein-tyrosine phosphatase inhibitor | 0.372 0.01 CHEMBL3544802 0.145 0.083 CHEMBL1647 0.15 0.078 CHEMBL3544871 | CHEMBL3544802 | |
| 0.042 | 0.008 | 0.042 | Glutamate (mGluR3) agonist | |||
| 0.088 | 0.054 | 0.2 | Hematopoietic | 0.2 0.01 CHEMBL3544870 0.094 0.043 CHEMBL3544871 | CHEMBL3544870 | |
| 0.054 | 0.021 | 0.183 | Mannosidase inhibitor | 0.069 0.012 CHEMBL3544802 0.183 0.003 CHEMBL1647 | CHEMBL1647 | |
| 0.13 | 0.097 | 0.16 | Thiol protease inhibitor | 0.127 0.102 CHEMBL33232 0.16 0.061 CHEMBL3544870 | CHEMBL3544870 | |
| 0.071 | 0.039 | 0.071 | Histone deacetylase inhibitor | |||
| 0.084 | 0.051 | 0.111 | Thioredoxin reductase inhibitor | 0.111 0.021 CHEMBL33232 | CHEMBL33232 | |
| 0.036 | 0.003 | 0.036 | Estrogen-related receptor gamma agonist | |||
| 0.106 | 0.075 | 0.151 | Acetylcholine release stimulant | 0.151 0.016 CHEMBL3544802 0.132 0.032 CHEMBL33232 0.113 0.06 CHEMBL1647 | CHEMBL3544802 | |
| 0.053 | 0.023 | 0.053 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.103 | 0.072 | 0.152 | Nav1.4 sodium channel blocker | 0.152 0.033 CHEMBL3544802 0.127 0.046 CHEMBL3544870 0.106 0.067 CHEMBL3544871 | CHEMBL3544802 | |
| 0.053 | 0.023 | 0.053 | Adenylate cyclase 1 inhibitor | 0.042 0.039 CHEMBL33232 | ||
| 0.079 | 0.049 | 0.079 | Estrogen receptor alpha antagonist | |||
| 0.084 | 0.055 | 0.084 | I kappa B kinase inhibitor | |||
| 0.051 | 0.023 | 0.051 | Oxytocin agonist | |||
| 0.059 | 0.031 | 0.169 | Estrogen agonist | 0.169 0.01 CHEMBL3544802 | CHEMBL3544802 | |
| 0.036 | 0.009 | 0.036 | Purinergic P2Y15 antagonist | 0.033 0.013 CHEMBL33232 | ||
| 0.051 | 0.023 | 0.051 | Glutamate (mGluR group III) agonist | |||
| 0.04 | 0.012 | 0.04 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.036 | 0.01 | 0.036 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.074 | 0.048 | 0.074 | Epoxide hydrolase inhibitor | 0.074 0.049 CHEMBL3544802 | ||
| 0.039 | 0.013 | 0.039 | Protein kinase (CK2) beta inhibitor | |||
| 0.206 | 0.181 | 0.465 | Beta lactamase inhibitor | 0.465 0.082 CHEMBL3544802 | CHEMBL3544802 | |
| 0.044 | 0.018 | 0.044 | Potassium channel Kv1.1 blocker | 0.041 0.021 CHEMBL33232 | ||
| 0.055 | 0.03 | 0.055 | Vanilloid 2 antagonist | 0.048 0.047 CHEMBL3544870 | ||
| 0.045 | 0.02 | 0.073 | Estrogen receptor beta agonist | 0.073 0.015 CHEMBL3544802 | CHEMBL3544802 | |
| 0.062 | 0.037 | 0.062 | Xanthine dehydrogenase inhibitor | |||
| 0.045 | 0.02 | 0.045 | Histone deacetylase 9 inhibitor | |||
| 0.045 | 0.021 | 0.045 | Alpha 1d adrenoreceptor agonist | |||
| 0.11 | 0.086 | 0.11 | Nav1.3 sodium channel blocker | |||
| 0.058 | 0.034 | 0.058 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.169 | 0.146 | 0.257 | Spasmolytic | 0.257 0.088 CHEMBL1647 | CHEMBL1647 | |
| 0.049 | 0.026 | 0.049 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.087 | 0.063 | 0.132 | ATPase (Vacuolar H+) inhibitor | 0.132 0.013 CHEMBL1647 | CHEMBL1647 | |
| 0.042 | 0.019 | 0.042 | Leukotriene C4 antagonist | |||
| 0.037 | 0.014 | 0.037 | Epoxide hydrolase 1 inhibitor | 0.033 0.019 CHEMBL33232 | ||
| 0.066 | 0.045 | 0.407 | Selectin antagonist | 0.286 0.006 CHEMBL3544802 0.407 0.003 CHEMBL1647 0.124 0.021 CHEMBL3544870 0.067 0.044 CHEMBL3544871 | CHEMBL1647 | |
| 0.116 | 0.094 | 0.165 | Cytokine production inhibitor | 0.165 0.052 CHEMBL33232 | CHEMBL33232 | |
| 0.073 | 0.051 | 0.124 | Metalloproteinase-9 inhibitor | 0.124 0.023 CHEMBL3544870 0.097 0.034 CHEMBL3544871 | CHEMBL3544870 | |
| 0.061 | 0.04 | 0.071 | Carbonic anhydrase stimulant | 0.071 0.031 CHEMBL3544870 | CHEMBL3544870 | |
| 0.103 | 0.083 | 0.148 | DNA polymerase I inhibitor | 0.148 0.05 CHEMBL1647 | CHEMBL1647 | |
| 0.15 | 0.13 | 0.15 | EphB2 antagonist | |||
| 0.051 | 0.031 | 0.06 | Factor III inhibitor | 0.06 0.018 CHEMBL1647 | CHEMBL1647 | |
| 0.043 | 0.024 | 0.043 | Kainate receptor agonist | 0.038 0.037 CHEMBL33232 | ||
| 0.031 | 0.012 | 0.031 | Nicotinic acid receptor 2 antagonist | 0.025 0.021 CHEMBL33232 | ||
| 0.032 | 0.013 | 0.032 | CXC chemokine 2 receptor antagonist | |||
| 0.028 | 0.01 | 0.028 | Beta 1 adrenoreceptor agonist | |||
| 0.039 | 0.02 | 0.039 | Phosphoglycerate kinase inhibitor | 0.039 0.02 CHEMBL3544802 | ||
| 0.059 | 0.041 | 0.059 | Gonadotropin-releasing hormone receptor agonist | 0.057 0.047 CHEMBL3544870 | ||
| 0.037 | 0.019 | 0.037 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.054 | 0.036 | 0.054 | Alpha tubulin antagonist | |||
| 0.024 | 0.006 | 0.024 | Carbonic anhydrase VIII inhibitor | 0.017 0.011 CHEMBL33232 | ||
| 0.024 | 0.006 | 0.024 | Carbonic anhydrase X inhibitor | 0.017 0.011 CHEMBL33232 | ||
| 0.035 | 0.017 | 0.035 | Estrogen-related receptor beta antagonist | |||
| 0.049 | 0.031 | 0.158 | Phosphorylase inhibitor | 0.158 0.007 CHEMBL1647 | CHEMBL1647 | |
| 0.062 | 0.044 | 0.062 | Phosphodiesterase 1C inhibitor | |||
| 0.024 | 0.007 | 0.065 | Ileal bile acid transport inhibitor | 0.065 0.003 CHEMBL1647 0.051 0.004 CHEMBL3544870 0.042 0.004 CHEMBL3544871 | CHEMBL1647 | |
| 0.04 | 0.023 | 0.04 | Histone deacetylase 7 inhibitor | |||
| 0.075 | 0.058 | 0.148 | Metalloproteinase-2 inhibitor | 0.148 0.019 CHEMBL3544870 0.122 0.028 CHEMBL3544871 | CHEMBL3544870 | |
| 0.054 | 0.037 | 0.373 | NMDA 2B receptor antagonist | 0.373 0.004 CHEMBL3544802 | CHEMBL3544802 | |
| 0.056 | 0.04 | 0.059 | Pregnane X receptor antagonist | 0.059 0.034 CHEMBL33232 | CHEMBL33232 | |
| 0.059 | 0.042 | 0.262 | HIV-1 integrase (Strand Transfer) inhibitor | 0.262 0.005 CHEMBL3544802 | CHEMBL3544802 | |
| 0.043 | 0.027 | 0.043 | Histone deacetylase 8 inhibitor | |||
| 0.025 | 0.01 | 0.025 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.037 | 0.021 | 0.037 | Fumarate hydratase inhibitor | 0.037 0.021 CHEMBL33232 | ||
| 0.111 | 0.095 | 0.118 | Nav1.2 sodium channel blocker | 0.118 0.086 CHEMBL3544802 | CHEMBL3544802 | |
| 0.049 | 0.034 | 0.049 | Dopamine beta hydroxylase inhibitor | |||
| 0.051 | 0.036 | 0.061 | Aconitate hydratase inhibitor | 0.061 0.025 CHEMBL33232 | CHEMBL33232 | |
| 0.035 | 0.02 | 0.043 | Melatonin 2 agonist | 0.043 0.014 CHEMBL33232 | CHEMBL33232 | |
| 0.067 | 0.053 | 0.067 | Prostaglandin-E synthase inhibitor | |||
| 0.118 | 0.103 | 0.118 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.054 | 0.04 | 0.054 | Glucosylceramidase inhibitor | |||
| 0.047 | 0.033 | 0.047 | Adenosine deaminase inhibitor | 0.043 0.037 CHEMBL1647 | ||
| 0.081 | 0.067 | 0.081 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.018 | 0.005 | 0.018 | Carbonic anhydrase XI inhibitor | 0.015 0.006 CHEMBL3544802 | ||
| 0.043 | 0.03 | 0.043 | Nerve growth factor antagonist | |||
| 0.072 | 0.059 | 0.077 | Vanilloid 4 agonist | 0.077 0.047 CHEMBL33232 | CHEMBL33232 | |
| 0.048 | 0.035 | 0.048 | Adenosine A2b receptor antagonist | |||
| 0.035 | 0.023 | 0.035 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.034 | 0.022 | 0.034 | Sirtuin 2 inhibitor | |||
| 0.02 | 0.009 | 0.02 | Potassium channel (Inward rectifier) 11 blocker | |||
| 0.034 | 0.023 | 0.034 | Carnitine palmitoyltransferase inhibitor | |||
| 0.036 | 0.024 | 0.036 | Nicotinic acid receptor 2 agonist | |||
| 0.064 | 0.053 | 0.096 | Sirtuin 1 inhibitor | 0.096 0.025 CHEMBL3544870 0.084 0.033 CHEMBL3544871 | CHEMBL3544870 | |
| 0.039 | 0.028 | 0.039 | CF transmembrane conductance regulator antagonist | |||
| 0.144 | 0.133 | 0.144 | Death-associated protein kinase 3 inhibitor | |||
| 0.031 | 0.02 | 0.031 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.079 | 0.068 | 0.087 | Ornithine decarboxylase inhibitor | 0.087 0.059 CHEMBL3544870 | CHEMBL3544870 | |
| 0.129 | 0.118 | 0.129 | MAP kinase kinase 4 inhibitor | |||
| 0.034 | 0.024 | 0.034 | Estrogen receptor alpha agonist | |||
| 0.014 | 0.004 | 0.014 | Thyroid hormone beta agonist | |||
| 0.032 | 0.022 | 0.032 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.055 | 0.044 | 0.055 | Cyclin E inhibitor | |||
| 0.053 | 0.043 | 0.053 | Sphingosine kinase 2 inhibitor | |||
| 0.016 | 0.006 | 0.016 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.014 0.008 CHEMBL33232 | ||
| 0.023 | 0.014 | 0.023 | Protease (Human cytomegalovirus) inhibitor | 0.021 0.017 CHEMBL33232 | ||
| 0.126 | 0.117 | 0.126 | MAP kinase 3 inhibitor | |||
| 0.075 | 0.067 | 0.075 | Neuropeptide Y antagonist | |||
| 0.053 | 0.044 | 0.104 | Beta tubulin antagonist | 0.104 0.021 CHEMBL3544871 | CHEMBL3544871 | |
| 0.098 | 0.09 | 0.114 | Cholesterol synthesis inhibitor | 0.114 0.071 CHEMBL3544802 0.1 0.088 CHEMBL33232 | CHEMBL3544802 | |
| 0.018 | 0.009 | 0.018 | Adenosine A2 receptor agonist | |||
| 0.03 | 0.022 | 0.03 | Cyclophilin A inhibitor | |||
| 0.061 | 0.052 | 0.08 | Interferon inducer | 0.08 0.024 CHEMBL1647 | CHEMBL1647 | |
| 0.038 | 0.031 | 0.193 | Toll-Like receptor 2 agonist | 0.038 0.032 CHEMBL1647 0.193 0.008 CHEMBL3544870 0.065 0.019 CHEMBL3544871 | CHEMBL3544870 | |
| 0.046 | 0.039 | 0.062 | Bombesin 2 receptor antagonist | 0.062 0.023 CHEMBL3544870 | CHEMBL3544870 | |
| 0.079 | 0.072 | 0.169 | Transcription factor NF kappa B stimulant | 0.169 0.013 CHEMBL1647 0.099 0.039 CHEMBL3544870 | CHEMBL1647 | |
| 0.021 | 0.014 | 0.021 | Factor XIII inhibitor | |||
| 0.02 | 0.013 | 0.023 | Caspase 8 inhibitor | 0.023 0.009 CHEMBL3544871 | CHEMBL3544871 | |
| 0.068 | 0.062 | 0.106 | Na+ K+ transporting ATPase inhibitor | 0.074 0.056 CHEMBL3544802 0.106 0.026 CHEMBL1647 | CHEMBL1647 | |
| 0.019 | 0.013 | 0.031 | Antibiotic Anthracycline-like | 0.031 0.004 CHEMBL1647 | CHEMBL1647 | |
| 0.034 | 0.028 | 0.064 | Arginase inhibitor | 0.064 0.009 CHEMBL1647 0.049 0.016 CHEMBL3544870 | CHEMBL1647 | |
| 0.037 | 0.031 | 0.051 | Membrane dipeptidase inhibitor | 0.036 0.033 CHEMBL33232 0.046 0.019 CHEMBL3544870 0.051 0.015 CHEMBL3544871 | CHEMBL3544871 | |
| 0.036 | 0.03 | 0.036 | Histone deacetylase class I inhibitor | |||
| 0.048 | 0.042 | 0.083 | Ornithine carbamoyltransferase inhibitor | 0.083 0.021 CHEMBL3544870 | CHEMBL3544870 | |
| 0.131 | 0.125 | 0.131 | Tumour necrosis factor antagonist | |||
| 0.072 | 0.066 | 0.098 | Interferon agonist | 0.098 0.031 CHEMBL1647 | CHEMBL1647 | |
| 0.064 | 0.059 | 0.064 | Protein kinase C beta inhibitor | |||
| 0.051 | 0.046 | 0.051 | Epithelial sodium channel blocker | |||
| 0.079 | 0.075 | 0.084 | Interleukin 5 antagonist | 0.084 0.064 CHEMBL1647 | CHEMBL1647 | |
| 0.027 | 0.022 | 0.027 | Melatonin antagonist | |||
| 0.031 | 0.027 | 0.034 | Melatonin 1 agonist | 0.034 0.021 CHEMBL33232 | CHEMBL33232 | |
| 0.032 | 0.028 | 0.032 | Glutamate (mGluR4) agonist | |||
| 0.026 | 0.023 | 0.026 | Hedgehog signaling activator | |||
| 0.04 | 0.037 | 0.04 | Geranyltranstransferase inhibitor | |||
| 0.015 | 0.012 | 0.015 | Thromboxane A2 agonist | |||
| 0.021 | 0.017 | 0.052 | Glutamate (mGluR1a) agonist | 0.052 0.005 CHEMBL3544802 | CHEMBL3544802 | |
| 0.079 | 0.076 | 0.079 | MAO B inhibitor | |||
| 0.077 | 0.074 | 0.077 | Opioid antagonist | |||
| 0.12 | 0.117 | 0.152 | CC chemokine 6 receptor antagonist | 0.152 0.02 CHEMBL1647 | CHEMBL1647 | |
| 0.244 | 0.241 | 0.244 | MAP kinase 1 inhibitor | |||
| 0.08 | 0.078 | 0.092 | Bromodomain-containing protein 2 inhibitor | 0.092 0.051 CHEMBL33232 | CHEMBL33232 | |
| 0.044 | 0.042 | 0.058 | Benzodiazepine antagonist | 0.058 0.015 CHEMBL33232 | CHEMBL33232 | |
| 0.03 | 0.028 | 0.03 | Melatonin agonist | |||
| 0.068 | 0.066 | 0.078 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.078 0.04 CHEMBL33232 | CHEMBL33232 | |
| 0.049 | 0.047 | 0.049 | Phosphatidylinositol 3-kinase gamma inhibitor | |||
| 0.007 | 0.006 | 0.007 | DNA topoisomerase III inhibitor | |||
| 0.017 | 0.016 | 0.017 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.015 CHEMBL33232 | ||
| 0.027 | 0.026 | 0.04 | Caspase 2 inhibitor | 0.034 0.02 CHEMBL3544870 0.04 0.016 CHEMBL3544871 | CHEMBL3544871 | |
| 0.035 | 0.037 | 0.037 | Vanilloid 3 antagonist | 0.037 0.03 CHEMBL33232 | CHEMBL33232 | |
| 0.044 | 0.047 | 0.059 | Cytokine production stimulant | 0.059 0.014 CHEMBL1647 | CHEMBL1647 | |
| 0.022 | 0.024 | 0.03 | Glutamate (mGluR1) agonist | 0.03 0.01 CHEMBL3544802 | CHEMBL3544802 | |
| 0.022 | 0.026 | 0.036 | Vanilloid 2 agonist | 0.036 0.005 CHEMBL1647 | CHEMBL1647 | |
| 0.015 | 0.019 | 0.021 | Telomerase stimulant | 0.021 0.007 CHEMBL1647 | CHEMBL1647 | |
| 0.022 | 0.026 | 0.035 | Uridine phosphorylase inhibitor | 0.035 0.014 CHEMBL1647 | CHEMBL1647 | |
| 0.099 | 0.103 | 0.104 | Tubulin antagonist | 0.104 0.098 CHEMBL3544871 | CHEMBL3544871 | |
| 0.124 | 0.129 | 0.392 | Nitric oxide antagonist | 0.392 0.026 CHEMBL1647 | CHEMBL1647 | |
| 0.029 | 0.035 | 0.035 | Melatonin receptor 1A agonist | 0.035 0.019 CHEMBL33232 | CHEMBL33232 | |
| 0.061 | 0.068 | 0.178 | Cathepsin G inhibitor | 0.178 0.018 CHEMBL3544802 | CHEMBL3544802 | |
| 0.065 | 0.073 | 0.084 | Somatostatin 1 agonist | 0.084 0.047 CHEMBL3544870 | CHEMBL3544870 | |
| 0.026 | 0.033 | 0.03 | Calcitonin receptor agonist | 0.03 0.027 CHEMBL3544870 | CHEMBL3544870 | |
| 0.1 | 0.107 | 0.166 | Bone formation stimulant | 0.166 0.048 CHEMBL3544870 0.14 0.067 CHEMBL3544871 | CHEMBL3544870 | |
| 0.052 | 0.061 | 0.123 | Neutrophil collagenase inhibitor | 0.123 0.016 CHEMBL3544870 0.071 0.039 CHEMBL3544871 | CHEMBL3544870 | |
| 0.026 | 0.036 | 0.029 | Caspase 6 inhibitor | 0.029 0.024 CHEMBL3544871 | CHEMBL3544871 | |
| 0.02 | 0.03 | 0.029 | Lysine carboxypeptidase inhibitor | 0.029 0.017 CHEMBL3544870 | CHEMBL3544870 | |
| 0.062 | 0.073 | 0.075 | Phospholipase D inhibitor | 0.075 0.042 CHEMBL3544802 | CHEMBL3544802 | |
| 0.036 | 0.048 | 0.076 | Thymidylate synthase inhibitor | 0.076 0.009 CHEMBL3544870 0.068 0.013 CHEMBL3544871 | CHEMBL3544870 | |
| 0.007 | 0.019 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.006 CHEMBL1647 | CHEMBL1647 | |
| 0.059 | 0.072 | 0.095 | HIV-1 integrase inhibitor | 0.095 0.028 CHEMBL3544802 | CHEMBL3544802 | |
| 0.033 | 0.049 | 0.228 | Leukocyte elastase inhibitor | 0.228 0.004 CHEMBL3544802 | CHEMBL3544802 | |
| 0.071 | 0.087 | 0.134 | Caspase 7 inhibitor | 0.134 0.01 CHEMBL33232 | CHEMBL33232 | |
| 0.059 | 0.076 | 0.081 | Exportin-1 inhibitor | 0.081 0.024 CHEMBL33232 | CHEMBL33232 | |
| 0.017 | 0.034 | 0.068 | Protein 30S ribosomal subunit inhibitor | 0.068 0.005 CHEMBL1647 | CHEMBL1647 | |
| 0.029 | 0.046 | 0.064 | Erythropoietin receptor agonist | 0.064 0.016 CHEMBL3544870 0.043 0.026 CHEMBL3544871 | CHEMBL3544870 | |
| 0.074 | 0.092 | 0.122 | Breast cancer-resistant protein inhibitor | 0.122 0.038 CHEMBL3544802 | CHEMBL3544802 | |
| 0.034 | 0.052 | 0.062 | Matrix metalloproteinase 1 inhibitor | 0.062 0.03 CHEMBL3544870 | CHEMBL3544870 | |
| 0.051 | 0.069 | 0.087 | CDC25B inhibitor | 0.087 0.023 CHEMBL3544871 | CHEMBL3544871 | |
| 0.082 | 0.1 | 0.21 | Protein-tyrosine phosphatase 1B inhibitor | 0.21 0.027 CHEMBL3544802 0.126 0.059 CHEMBL1647 0.093 0.085 CHEMBL3544871 | CHEMBL3544802 | |
| 0.06 | 0.079 | 0.186 | CDC25A inhibitor | 0.186 0.008 CHEMBL3544802 0.095 0.03 CHEMBL3544871 | CHEMBL3544802 | |
| 0.023 | 0.042 | 0.029 | Cholesterol ester transfer protein antagonist | 0.029 0.026 CHEMBL3544802 | CHEMBL3544802 | |
| 0.02 | 0.04 | 0.082 | Sodium/glucose cotransporter inhibitor | 0.082 0.003 CHEMBL1647 | CHEMBL1647 | |
| 0.048 | 0.069 | 0.098 | Matrix metalloproteinase inhibitor | 0.098 0.027 CHEMBL3544870 0.068 0.046 CHEMBL3544871 | CHEMBL3544870 | |
| 0.069 | 0.091 | 0.125 | Falcipain inhibitor | 0.125 0.042 CHEMBL1647 | CHEMBL1647 | |
| 0.009 | 0.032 | 0.017 | Aminopeptidase A inhibitor | 0.017 0.013 CHEMBL3544870 | CHEMBL3544870 | |
| 0.019 | 0.042 | 0.04 | Calcium-sensing receptor agonist | 0.04 0.007 CHEMBL3544870 | CHEMBL3544870 | |
| 0.042 | 0.066 | 0.054 | Matrix metalloproteinase (membrane-type) inhibitor | 0.054 0.039 CHEMBL3544870 | CHEMBL3544870 | |
| 0.02 | 0.045 | 0.024 | Complement factor 1s inhibitor | 0.024 0.023 CHEMBL33232 | CHEMBL33232 | |
| 0.027 | 0.051 | 0.034 | Benzodiazepine receptor peripheral-type antagonist | 0.034 0.024 CHEMBL33232 | CHEMBL33232 | |
| 0.034 | 0.058 | 0.06 | Neuropeptide agonist | 0.06 0.038 CHEMBL3544870 | CHEMBL3544870 | |
| 0.031 | 0.056 | 0.045 | Histamine H2 receptor agonist | 0.045 0.027 CHEMBL33232 | CHEMBL33232 | |
| 0.076 | 0.1 | 0.122 | Gastric antisecretory | 0.122 0.041 CHEMBL3544802 | CHEMBL3544802 | |
| 0.066 | 0.093 | 0.12 | Falcipain 2 inhibitor | 0.12 0.042 CHEMBL1647 | CHEMBL1647 | |
| 0.054 | 0.081 | 0.104 | Histone deacetylase stimulant | 0.104 0.025 CHEMBL1647 | CHEMBL1647 | |
| 0.054 | 0.081 | 0.104 | Histone deacetylase SIRT1 stimulant | 0.104 0.025 CHEMBL1647 | CHEMBL1647 | |
| 0.021 | 0.049 | 0.041 | Toll-Like receptor 4 agonist | 0.041 0.005 CHEMBL3544802 0.038 0.005 CHEMBL1647 | CHEMBL3544802 | |
| 0.02 | 0.048 | 0.108 | Leukotriene A4 hydrolase inhibitor | 0.087 0.007 CHEMBL3544870 0.108 0.005 CHEMBL3544871 | CHEMBL3544871 | |
| 0.017 | 0.046 | 0.088 | Sodium/glucose cotransporter 2 inhibitor | 0.088 0.003 CHEMBL1647 | CHEMBL1647 | |
| 0.009 | 0.038 | 0.016 | Thyroid hormone alpha antagonist | 0.016 0.01 CHEMBL3544871 | CHEMBL3544871 | |
| 0.021 | 0.051 | 0.041 | 1,3-Beta-glucan synthase inhibitor | 0.041 0.004 CHEMBL3544802 0.03 0.015 CHEMBL1647 | CHEMBL3544802 | |
| 0.12 | 0.151 | 0.448 | Hepatoprotectant | 0.164 0.095 CHEMBL3544802 0.448 0.01 CHEMBL1647 0.225 0.052 CHEMBL3544870 0.144 0.116 CHEMBL3544871 | CHEMBL1647 | |
| 0.03 | 0.062 | 0.047 | Neurotensin receptor antagonist | 0.047 0.03 CHEMBL3544870 | CHEMBL3544870 | |
| 0.031 | 0.07 | 0.045 | Dihydrofolate reductase inhibitor | 0.045 0.028 CHEMBL3544802 | CHEMBL3544802 | |
| 0.122 | 0.16 | 0.134 | Lipocortins synthesis antagonist | 0.134 0.132 CHEMBL33232 | CHEMBL33232 | |
| 0.081 | 0.12 | 0.11 | Beta amyloid protein antagonist | 0.11 0.077 CHEMBL1647 | CHEMBL1647 | |
| 0.022 | 0.062 | 0.071 | Purinergic P2Y2 antagonist | 0.071 0.006 CHEMBL3544802 | CHEMBL3544802 | |
| 0.048 | 0.087 | 0.059 | Caspase 9 inhibitor | 0.058 0.051 CHEMBL3544870 0.059 0.049 CHEMBL3544871 | CHEMBL3544871 | |
| 0.038 | 0.077 | 0.052 | Leukotriene B4 antagonist | 0.052 0.039 CHEMBL1647 | CHEMBL1647 | |
| 0.015 | 0.056 | 0.033 | Bradykinin B2 receptor agonist | 0.033 0.015 CHEMBL3544870 | CHEMBL3544870 | |
| 0.027 | 0.069 | 0.054 | Antimetabolite | 0.054 0.029 CHEMBL3544870 | CHEMBL3544870 | |
| 0.014 | 0.058 | 0.031 | Prostacyclin antagonist | 0.031 0.025 CHEMBL3544871 | CHEMBL3544871 | |
| 0.034 | 0.077 | 0.052 | Collagenase inhibitor | 0.052 0.029 CHEMBL3544870 0.051 0.029 CHEMBL3544871 | CHEMBL3544870 | |
| 0.072 | 0.116 | 0.092 | Nitric-oxide synthase inhibitor | 0.092 0.075 CHEMBL33232 | CHEMBL33232 | |
| 0.031 | 0.078 | 0.048 | VCAM-1 antagonist | 0.042 0.021 CHEMBL3544870 0.048 0.011 CHEMBL3544871 | CHEMBL3544871 | |
| 0.031 | 0.078 | 0.047 | VCAM antagonist | 0.041 0.021 CHEMBL3544870 0.047 0.011 CHEMBL3544871 | CHEMBL3544871 | |
| 0.067 | 0.116 | 0.123 | Uric acid excretion stimulant | 0.123 0.036 CHEMBL1647 | CHEMBL1647 | |
| 0.061 | 0.114 | 0.09 | Histamine H2 receptor antagonist | 0.09 0.047 CHEMBL33232 | CHEMBL33232 | |
| 0.023 | 0.079 | 0.041 | Growth hormone release inhibitor | 0.041 0.031 CHEMBL3544870 | CHEMBL3544870 | |
| 0.008 | 0.064 | 0.163 | Estrone sulfatase inhibitor | 0.163 0.003 CHEMBL3544802 | CHEMBL3544802 | |
| 0.045 | 0.102 | 0.096 | Lipocortins synthesis agonist | 0.096 0.006 CHEMBL33232 0.067 0.024 CHEMBL1647 | CHEMBL33232 | |
| 0.012 | 0.069 | 0.022 | Dopamine D1 agonist | 0.022 0.017 CHEMBL1647 | CHEMBL1647 | |
| 0.031 | 0.089 | 0.048 | Aldosterone antagonist | 0.048 0.032 CHEMBL33232 | CHEMBL33232 | |
| 0.041 | 0.099 | 0.058 | Transcription factor AP-1 inhibitor | 0.058 0.049 CHEMBL1647 | CHEMBL1647 | |
| 0.075 | 0.134 | 0.281 | Multidrug resistance-associated protein 1 inhibitor | 0.281 0.004 CHEMBL3544802 0.113 0.058 CHEMBL1647 | CHEMBL3544802 | |
| 0.14 | 0.199 | 0.638 | Hypoglycemic | 0.638 0.006 CHEMBL1647 | CHEMBL1647 | |
| 0.006 | 0.068 | 0.049 | VLA-4 antagonist | 0.049 0.013 CHEMBL3544871 | CHEMBL3544871 | |
| 0.058 | 0.123 | 0.215 | Topoisomerase I inhibitor | 0.215 0.023 CHEMBL1647 | CHEMBL1647 | |
| 0.018 | 0.084 | 0.171 | Factor Xa inhibitor | 0.171 0.007 CHEMBL3544802 0.047 0.031 CHEMBL1647 | CHEMBL3544802 | |
| 0.103 | 0.169 | 0.415 | Platelet adhesion inhibitor | 0.376 0.014 CHEMBL3544802 0.415 0.01 CHEMBL1647 | CHEMBL1647 | |
| 0.138 | 0.206 | 0.164 | MAP kinase kinase 5 inhibitor | 0.164 0.104 CHEMBL33232 | CHEMBL33232 | |
| 0.167 | 0.234 | 0.502 | Immunosuppressant | 0.502 0.032 CHEMBL1647 | CHEMBL1647 | |
| 0.023 | 0.092 | 0.059 | Aldose reductase inhibitor | 0.059 0.032 CHEMBL1647 | CHEMBL1647 | |
| 0.06 | 0.129 | 0.123 | Aminoacyl-tRNA synthetase inhibitor | 0.123 0.028 CHEMBL3544870 | CHEMBL3544870 | |
| 0.021 | 0.091 | 0.045 | Integrin alpha5beta1 antagonist | 0.045 0.023 CHEMBL3544870 | CHEMBL3544870 | |
| 0.055 | 0.125 | 0.08 | Inducible nitric-oxide synthase inhibitor | 0.08 0.062 CHEMBL33232 | CHEMBL33232 | |
| 0.025 | 0.098 | 0.04 | Plasmin inhibitor | 0.04 0.038 CHEMBL3544802 | CHEMBL3544802 | |
| 0.022 | 0.096 | 0.081 | Antibiotic Aminoglycoside-like | 0.081 0.004 CHEMBL1647 | CHEMBL1647 | |
| 0.028 | 0.106 | 0.044 | Bombesin antagonist | 0.044 0.041 CHEMBL3544870 | CHEMBL3544870 | |
| 0.053 | 0.132 | 0.092 | Chymotrypsin inhibitor | 0.092 0.042 CHEMBL3544802 0.079 0.056 CHEMBL3544870 | CHEMBL3544802 | |
| 0.055 | 0.136 | 0.125 | Protease inhibitor | 0.125 0.044 CHEMBL3544870 0.106 0.06 CHEMBL3544871 | CHEMBL3544870 | |
| 0.036 | 0.122 | 0.071 | Angiotensin-converting enzyme inhibitor | 0.068 0.021 CHEMBL3544870 0.071 0.019 CHEMBL3544871 | CHEMBL3544871 | |
| 0.049 | 0.14 | 0.115 | Epidermal growth factor antagonist | 0.115 0.035 CHEMBL33232 | CHEMBL33232 | |
| 0.018 | 0.109 | 0.049 | Endothelin-converting enzyme inhibitor | 0.049 0.031 CHEMBL3544870 0.041 0.037 CHEMBL3544871 | CHEMBL3544870 | |
| 0.031 | 0.122 | 0.199 | Antineoplastic antibiotic | 0.199 0.021 CHEMBL1647 | CHEMBL1647 | |
| 0.057 | 0.152 | 0.189 | DNA intercalator | 0.189 0.029 CHEMBL33232 0.139 0.047 CHEMBL1647 | CHEMBL33232 | |
| 0.019 | 0.114 | 0.963 | Cholecystokinin B agonist | 0.963 0.001 CHEMBL3544802 0.041 0.023 CHEMBL3544870 | CHEMBL3544802 | |
| 0.012 | 0.107 | 0.113 | NMDA 2D receptor antagonist | 0.113 0.004 CHEMBL3544802 | CHEMBL3544802 | |
| 0.015 | 0.11 | 0.063 | Dopamine D2 agonist | 0.063 0.02 CHEMBL3544802 | CHEMBL3544802 | |
| 0.008 | 0.103 | 0.628 | Cholecystokinin A antagonist | 0.628 0.002 CHEMBL3544802 0.034 0.028 CHEMBL3544870 | CHEMBL3544802 | |
| 0.006 | 0.101 | 0.562 | Cholecystokinin B antagonist | 0.562 0.003 CHEMBL3544802 | CHEMBL3544802 | |
| 0.027 | 0.123 | 0.061 | Aminopeptidase microsomal inhibitor | 0.061 0.038 CHEMBL3544870 | CHEMBL3544870 | |
| 0.003 | 0.103 | 0.018 | Glucocorticoid agonist | 0.018 0.008 CHEMBL33232 | CHEMBL33232 | |
| 0.072 | 0.172 | 0.331 | Thrombolytic | 0.204 0.05 CHEMBL3544802 0.331 0.019 CHEMBL1647 0.318 0.021 CHEMBL3544870 0.21 0.047 CHEMBL3544871 | CHEMBL1647 | |
| 0.009 | 0.11 | 0.586 | Cholecystokinin antagonist | 0.586 0.003 CHEMBL3544802 0.046 0.027 CHEMBL3544870 | CHEMBL3544802 | |
| 0.011 | 0.113 | 0.039 | Protocollagen prolyl hydroxylase inhibitor | 0.039 0.008 CHEMBL3544870 | CHEMBL3544870 | |
| 0.016 | 0.121 | 0.05 | HIV-1 protease inhibitor | 0.049 0.023 CHEMBL3544870 0.05 0.021 CHEMBL3544871 | CHEMBL3544871 | |
| 0.111 | 0.216 | 0.428 | Tumour necrosis factor alpha release inhibitor | 0.428 0.022 CHEMBL1647 | CHEMBL1647 | |
| 0.022 | 0.129 | 0.113 | Protein 50S ribosomal subunit inhibitor | 0.113 0.01 CHEMBL1647 | CHEMBL1647 | |
| 0.008 | 0.114 | 0.028 | Corticosteroid-like | 0.028 0.008 CHEMBL33232 | CHEMBL33232 | |
| 0.114 | 0.221 | 0.319 | Vasodilator | 0.319 0.042 CHEMBL1647 | CHEMBL1647 | |
| 0.005 | 0.112 | 0.032 | Integrin alpha4 antagonist | 0.032 0.015 CHEMBL3544871 | CHEMBL3544871 | |
| 0.017 | 0.125 | 0.043 | Aminopeptidase N inhibitor | 0.043 0.038 CHEMBL3544870 | CHEMBL3544870 | |
| 0.025 | 0.136 | 0.082 | Acetylcholine M5 receptor agonist | 0.082 0.033 CHEMBL33232 | CHEMBL33232 | |
| 0.025 | 0.138 | 0.096 | Glucagon-like peptide 1 agonist | 0.096 0.024 CHEMBL3544870 0.056 0.051 CHEMBL3544871 | CHEMBL3544870 | |
| 0.03 | 0.151 | 0.059 | Bombesin 1 receptor agonist | 0.059 0.042 CHEMBL3544870 | CHEMBL3544870 | |
| 0.07 | 0.192 | 0.317 | Cell adhesion inhibitor | 0.317 0.009 CHEMBL1647 0.111 0.073 CHEMBL3544870 0.148 0.048 CHEMBL3544871 | CHEMBL1647 | |
| 0.012 | 0.142 | 0.069 | Factor XI inhibitor | 0.069 0.005 CHEMBL3544802 | CHEMBL3544802 | |
| 0.016 | 0.147 | 0.08 | Factor XIa inhibitor | 0.08 0.008 CHEMBL3544802 | CHEMBL3544802 | |
| 0.041 | 0.176 | 0.06 | Trypsin inhibitor | 0.06 0.048 CHEMBL3544870 | CHEMBL3544870 | |
| 0.005 | 0.146 | 0.866 | Cholecystokinin agonist | 0.866 0.001 CHEMBL3544802 | CHEMBL3544802 | |
| 0.002 | 0.145 | 0.012 | Antibiotic Macrolide-like | 0.012 0.011 CHEMBL1647 | CHEMBL1647 | |
| 0.007 | 0.152 | 0.016 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.016 0.013 CHEMBL1647 | CHEMBL1647 | |
| 0.07 | 0.216 | 0.138 | Factor V inhibitor | 0.138 0.025 CHEMBL3544870 | CHEMBL3544870 | |
| 0.046 | 0.193 | 0.168 | Cell adhesion molecule inhibitor | 0.168 0.012 CHEMBL1647 | CHEMBL1647 | |
| 0.02 | 0.167 | 0.04 | Glutamate (mGluR8) antagonist | 0.04 0.017 CHEMBL3544870 | CHEMBL3544870 | |
| 0.005 | 0.153 | 0.85 | Cholecystokinin A agonist | 0.85 0.001 CHEMBL3544802 | CHEMBL3544802 | |
| 0.028 | 0.181 | 0.055 | Carbonic anhydrase II stimulant | 0.055 0.03 CHEMBL3544870 | CHEMBL3544870 | |
| 0.012 | 0.169 | 0.041 | Carbonic anhydrase I stimulant | 0.041 0.022 CHEMBL3544870 | CHEMBL3544870 | |
| 0.008 | 0.171 | 0.05 | Complement C3a chemotactic receptor antagonist | 0.05 0.027 CHEMBL3544870 | CHEMBL3544870 | |
| 0.023 | 0.186 | 0.071 | Nitric oxide donor | 0.071 0.032 CHEMBL1647 0.07 0.033 CHEMBL3544870 | CHEMBL1647 | |
| 0.009 | 0.173 | 0.048 | Integrin antagonist | 0.048 0.028 CHEMBL3544871 | CHEMBL3544871 | |
| 0.005 | 0.172 | 0.062 | GP IIb/IIIa receptor antagonist | 0.062 0.027 CHEMBL3544870 | CHEMBL3544870 | |
| 0.027 | 0.195 | 0.052 | Cathepsin B inhibitor | 0.052 0.045 CHEMBL3544870 | CHEMBL3544870 | |
| 0.02 | 0.194 | 0.13 | ATM kinase inhibitor | 0.13 0.003 CHEMBL33232 | CHEMBL33232 | |
| 0.062 | 0.238 | 0.127 | Folate antagonist | 0.127 0.033 CHEMBL3544870 0.109 0.05 CHEMBL3544871 | CHEMBL3544870 | |
| 0.019 | 0.195 | 0.045 | Microtubule stabilization | 0.045 0.034 CHEMBL1647 | CHEMBL1647 | |
| 0.057 | 0.237 | 0.093 | T cell inhibitor | 0.093 0.033 CHEMBL1647 | CHEMBL1647 | |
| 0.026 | 0.21 | 0.064 | DNA gyrase inhibitor | 0.064 0.043 CHEMBL1647 | CHEMBL1647 | |
| 0.044 | 0.229 | 0.095 | Factor XII inhibitor | 0.095 0.042 CHEMBL3544870 | CHEMBL3544870 | |
| 0.076 | 0.266 | 0.289 | Hypolipemic | 0.289 0.052 CHEMBL1647 0.177 0.112 CHEMBL3544871 | CHEMBL1647 | |
| 0.023 | 0.217 | 0.083 | Glucose-6-phosphate translocase inhibitor | 0.083 0.01 CHEMBL1647 | CHEMBL1647 | |
| 0.014 | 0.208 | 0.118 | DNA-dependent protein kinase inhibitor | 0.118 0.005 CHEMBL33232 | CHEMBL33232 | |
| 0.034 | 0.236 | 0.158 | Bcl-xL inhibitor | 0.103 0.006 CHEMBL3544870 0.158 0.004 CHEMBL3544871 | CHEMBL3544871 | |
| 0.005 | 0.209 | 0.031 | Squalene synthetase inhibitor | 0.031 0.023 CHEMBL1647 | CHEMBL1647 | |
| 0.056 | 0.267 | 0.589 | Anticoagulant | 0.589 0.006 CHEMBL3544802 0.267 0.035 CHEMBL1647 0.254 0.038 CHEMBL3544870 0.15 0.08 CHEMBL3544871 | CHEMBL3544802 | |
| 0.026 | 0.241 | 0.084 | MAP kinase kinase 10 inhibitor | 0.084 0.026 CHEMBL3544802 | CHEMBL3544802 | |
| 0.016 | 0.231 | 0.124 | Elastase inhibitor | 0.124 0.005 CHEMBL3544802 | CHEMBL3544802 | |
| 0.163 | 0.392 | 0.743 | Antiinflammatory | 0.275 0.239 CHEMBL3544802 0.743 0.023 CHEMBL1647 | CHEMBL1647 | |
| 0.069 | 0.307 | 0.252 | Insulin secretagoues | 0.252 0.019 CHEMBL1647 | CHEMBL1647 | |
| 0.102 | 0.353 | 0.471 | Immunomodulator | 0.471 0.028 CHEMBL1647 0.257 0.109 CHEMBL3544870 | CHEMBL1647 | |
| 0.021 | 0.275 | 0.039 | Integrin alpha1beta1 antagonist | 0.039 0.025 CHEMBL3544871 | CHEMBL3544871 | |
| 0.06 | 0.326 | 0.309 | Platelet antagonist | 0.309 0.05 CHEMBL1647 0.264 0.067 CHEMBL3544870 0.174 0.122 CHEMBL3544871 | CHEMBL1647 | |
| 0.024 | 0.305 | 0.153 | Bcl2 antagonist | 0.102 0.017 CHEMBL3544870 0.153 0.005 CHEMBL3544871 | CHEMBL3544871 | |
| 0.019 | 0.303 | 0.124 | Thrombin inhibitor | 0.124 0.017 CHEMBL3544802 0.064 0.063 CHEMBL3544870 | CHEMBL3544802 | |
| 0.015 | 0.312 | 0.039 | Neurokinin 2 agonist | 0.039 0.032 CHEMBL3544870 | CHEMBL3544870 | |
| 0.017 | 0.318 | 0.042 | Cathepsin F inhibitor | 0.042 0.027 CHEMBL3544870 | CHEMBL3544870 | |
| 0.006 | 0.307 | 0.023 | Motilin receptor agonist | 0.023 0.016 CHEMBL1647 | CHEMBL1647 | |
| 0.013 | 0.322 | 0.05 | H+/K+-transporting ATPase inhibitor | 0.05 0.037 CHEMBL3544802 | CHEMBL3544802 | |
| 0.007 | 0.385 | 0.122 | Phosphodiesterase 4A inhibitor | 0.122 0.012 CHEMBL33232 | CHEMBL33232 | |
| 0.082 | 0.529 | 0.747 | Cyclophilin D inhibitor | 0.747 0.01 CHEMBL1647 | CHEMBL1647 | |
| 0.041 | 0.575 | 0.253 | Antiobesity | 0.253 0.153 CHEMBL3544802 | CHEMBL3544802 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |